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 	Chapter 1.
Introduction	
1.1 Chromatin	structure	and	dynamics		
In	 eukaryotic	 cells,	 DNA	 requires	 an	 extreme	 arrangement	 in	 order	 to	 be	
accommodated	 within	 the	 nucleus.	 The	 compaction	 of	 the	 DNA	 sequence	 into	 a	
dynamic	chromatin	fibre	is	achieved	through	association	with	strongly	basic	histone	
and	 non‐histone	 proteins	 (Fig.	 1.1).	 Cytologically	 two	 functional	 forms	 of	 the	
chromatin	can	be	distinguished:	heterochromatin,	 a	 condensed	 form	during	mitosis	
and	meiosis	that	generally	lacks	DNA	regulatory	activity,	and	euchromatin	described	
as	 open,	 gene	 rich	 regions	 found	 often	 (but	 not	 always)	 under	 active	 transcription	
(Jenuwein	 and	 Allis,	 2001;	 Marmorstein,	 2001).	 Within	 the	 chromatin,	 the	
fundamental	 repeating	 unit	 is	 represented	 by	 the	 nucleosome	 which	 consists	 of	
147	bp	DNA	wrapped	around	a	histone	octamer	of	one	H3‐H4	tetramer	and	two	H2A‐
H2B	 dimers	 (Roth	 et	 al.,	 2001;	 Li	 et	 al.,	 2012).	 The	 neighbouring	 nucleosomes	 are	
connected	 by	 a	 segment	 of	 linker	 DNA	 that	 varies	 from	 10	 to	 80	 bp	 in	 length	
depending	 on	 species	 and	 cell	 type. The	 presence	 of	 a	 fifth	 histone	 protein H1	
stabilizes	the	assembly	of	the	octameric	core	into	a	higher‐order	chromatin	structure,	
the	30‐nm	fiber	(Woodcock	et	al.,	2006).	The	details	of	further	chromatin	folding	are	
still	uncertain	(Bassett	et	al.,	2009).	
 
Fig.	1.1	Different	levels	of	DNA	condensation	in	the	nucleus	(Felsenfeld	and	Groudine,	2003).
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Histones	are	small	basic	proteins	consisting	of	a	globular	domain	and	a	flexible,	
charged	NH2‐	and	COOH‐terminus	(histone	“tails”)	that	pass	over/between	the	gyres	
of	 the	 DNA	 superhelix	 (Luger	 et	 al.,	 1997).	 The	 histone	 tails	 are	 highly	 conserved	
across	various	species	and	are	subjected	to	extensive	post‐translational	modifications	
(PTMs),	 which	 are	 thought	 to	 contribute	 towards	 the	 formation	 of	 higher‐order	
chromatin	 structure	 (Fletcher	 and	Hansen,	1996;	Dutnall	 and	Ramakrishnan,	 1997;	
Luger	and	Richmond,	1998).	Besides	covalent	modifications	of	histone	proteins,	other	
types	of	mechanisms	have	been	 shown	 to	 contribute	 to	 the	dynamics	 of	 chromatin	
structure.	The	activity	of	large	ATP‐dependent	chromatin	remodelling	complexes	and	
the	 incorporation	 of	 histone	 variants	 are	 two	 mechanisms	 linked	 to	 chromatin	
higher‐order	structure.	While	the	first	mechanism	directly	alters	chromatin	structure	
(Bouazoune	et	al.,	2002),	the	subsequent	process	may	act	as	an	alternative	to	histone	
modifications	 for	 the	 generation	 of	 distinctive	 chromatin	 regions	 (Pusarla	 and	
Bhargava,	2005).	
 
Fig.	1.2	Schematic	drawing	of	a	nucleosome	with	post‐translational	modifications	of	 the	 four	
canonical	 histones	 (H2A,	 H2B,	 H3	 and	 H4)	 and	 the	 linker	 histone	 H1.	 The	 covalent	 PTMs	
[methylation	 (Me),	 acetylation	 (Ac),	 ubiquitination	 (Ub),	 and	 phosphorylation	 (Ph)]	 are	
highlighted	on	the	N‐	and	C‐terminal	tails	of	each	histone	(Tollervey	and	Lunyak,	2012).	
The	 amino	 terminal	 tail	 of	 histones	 has	 over	 60	 residues	 which	 have	 been	
shown	 to	 undergo	 enzymatic	 modifications	 in	 different	 cell	 types	 and	 during	
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developmental	stages	(Surani	et	al.,	2007;	Furdas	et	al.,	2012).	At	least	seven	covalent	
modifications	are	known	to	date:	acetylation	(at	lysine	residues),	methylation	(lysine	
and	 arginine),	 phosphorylation	 (serine	 and	 threonine),	 ubiquitination	 (lysine),	
sumoylation	 (lysine),	 ADP	 ribosylation	 (glutamate	 and	 lysine),	 deamination	
(arginine)	 as	 well	 as	 proline	 isomerization	 (Fig.	 1.2)	 (Kouzarides,	 2007).	
Combinations	of	post‐translational	marks	on	single	histones,	single	nucleosomes	and	
nucleosome	domains	 establish	 local	 and	global	patterns	of	 chromatin	modifications	
that	may	specify	unique	downstream	functions	(Strahl	and	Allis,	2000;	Turner,	2000).	
Furthermore,	 combinations	 of	 interactions	 between	 complexes	 define	 substrate	
specificity	and	regulate	the	proper	timing	for	covalent	modifications	on	nucleosomes	
and	chromatin	(Suganuma	and	Workman,	2011).	There	are	many	studies	which	have	
shown	 that	 the	 site‐specific	 combinations	 of	 covalent	 modifications	 collaborate	 to	
influence	 a	 multitude	 of	 cellular	 processes	 such	 as	 transcription,	 gene	 silencing,	
heterochromatization,	DNA	repair	and	replication	(Fig.	1.3)	(Munshi	et	al.,	2009).		
 
Fig.	 1.3	 Graphical	 representation	 of	 histone	 modifications	 and	 their	 biological	 functions	
(Munshi	et	al.,	2009).	
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It	has	been	hypothesized	that	addition,	interpretation	and	removal	of	the	post‐
translational	modification	marks	constitute	the	histone	code,	read	by	other	proteins	
or	protein	modules	and	regulate	chromatin	states	at	the	target	genes	(Strahl	and	Allis,	
2000).	 The	 structure	 of	 chromatin	 provides	 a	 unique	 possibility	 to	 preserve	 the	
established	arrangements	of	PTMs	through	cell	divisions	allowing	the	inheritance	of	
cell	 type‐speciﬁc	 gene	 expression	 patterns	 and	 thus	 to	 preserve	 cellular	 identity	
(Sawicka	and	Seiser,	2012).	
1.2 Histone	modifications	and	chromatin	regulation		
The	highly	dynamic	structure	of	chromatin	can	respond	to	external	stimuli	and	
regulate	 all	 DNA‐mediated	 processes	 within	 the	 nucleus.	 The	major	 players	 in	 the	
chromatin	 regulation	 pathway	 are	 the	 histone	 proteins	 and	 their	 covalent	
modifications	 (Bannister	 and	 Kouzarides,	 2011).	 It	 is	 proposed	 that	 histone	
modifications	function	as	signalling	platforms	recognized	by	protein	effectors.	In	turn,	
the	effectors	can	ultimately	determine	the	possible	outcome	of	certain	PTMs	(Yun	et	
al.,	 2011)	 which	 often	 depend	 on	 the	 chromatin	 and	 cellular	 context	 of	 such	
modifications	(Berger,	2007).	Proteins	that	are	directly	involved	in	post‐translational	
modifications	 are	 often	 classified	 into	 three	 functional	 families:	 the	 enzymes	which	
produce	 these	 modifications	 (the	 ‘writers’),	 the	 proteins	 that	 recognize	 them	 (the	
‘readers’),	and	the	enzymes	that	remove	them	(the	‘erasers’)	(Yost	et	al.,	2011).	Given	
the	 importance	 of	 chromatin	 regulation	 in	 cell	 biology,	 the	 ‘writers’,	 ‘readers’,	 and	
‘erasers’	 are	major	 targets	 for	manipulation	 to	 further	understand	 the	histone	code	
and	the	role	it	plays	in	the	progression	of	human	disease	(Fletcher	and	Hansen,	1996;	
Luger	and	Richmond,	1998).	
Post‐translational	 modification	 of	 histones	 together	 with	 DNA	 methylation	
contribute	to	the	epigenetic	 information	within	the	chromatin	(Munshi	et	al.,	2009).	
The	presence	of	different	covalent	modifications	can	alter	the	integrity	and	stability	of	
a	nucleosome.	For	example,	lysine	(K)	acetylation	(ac)	has	been	shown	to	modify	the	
secondary	structure	of	the	histone	tail,	weaken	the	interaction	between	the	histones	
and	DNA,	and	reduce	internucleosomal	interactions	and	chromatin	folding	(Fischle	et	
al.,	 2003).	 Histone	 H4	 acetylation	 at	 lysine	 16	 (H4K16ac)	 represents	 an	 essential	
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modification	 that	 can	 regulate	 the	 folding	 and	 chromatin	 alteration	 from	
heterochromatin	to	euchromatin	(Shahbazian	and	Grunstein,	2007).		
Phosphorylation	 of	 histone	 tails	 is	 controlled	 by	 the	 antagonistic	 action	 of	
protein	kinases	and	phosphatases.	The	addition	of	a	phosphate	group	from	ATP	to	the	
target	amino	acid	side	chain	and	its	removal	regulates	the	chromatin	structure	(Oki	et	
al.,	2007).	Histone	H3	phosphorylation	at	serine	(S)	10	and	28	are	important	covalent	
modifications	 for	 chromatin	 condensation	 and	 relaxation	 associated	 with	 mitosis,	
meiosis	and	transcription	activation,	respectively	(Rossetto	et	al.,	2012).	
According	 to	 recent	 studies	 different	 histone	methylations	 are	 recognized	 by	
‘readers’	 promoting	 the	 recruitment	 of	 other	 molecules	 that	 can	 regulate	 the	
chromatin	and	 transcription	states	 (Greer	and	Shi,	2012).	 In	contrast	 to	acetylation	
and	 phosphorylation,	 the	 methylation	 of	 lysines	 and	 arginines	 does	 not	 alter	 the	
charge	of	histone	proteins	 (Bannister	and	Kouzarides,	2011).	The	degrees	at	which	
histone	 tails	 are	 methylated	 by	 methyltransferase	 enzymes	 (mono‐,	 di‐,	 tri‐
methylation	of	 lysine;	mono‐,	 di‐symmetric	 or	 asymmetric	methylation	of	 arginine)	
have	 been	 associated	 with	 distinct	 gene	 expression	 patterns.	 For	 instance,	 histone	
H3K4	tri‐methylation	(me3)	is	generally	associated	with	active	transcription	or	genes	
that	 are	 ready	 for	 activation.	 In	 contrast,	 repressed	 chromatin	 is	 marked	 by	
H3K27me3	as	well	as	by	H3K9me3,	a	binding	platform	for	heterochromatin	protein	1	
(HP1)	(Bernstein	et	al.,	2002;	Santos‐Rosa	et	al.,	2002).	
ADP‐ribosylation	of	histones	by	poly‐ADP	ribose	polymerase	family	of	enzymes	
has	 also	 been	 associated	 with	 an	 open	 chromatin	 state	 (Hassa	 et	 al.,	 2006).	 The	
relaxation	of	the	chromatin	might	occur	due	to	the	negative	charge	of	the	ADP‐ribose	
unit	which	repels	 the	DNA	(Messner	and	Hottiger,	2011).	Little	 is	known	about	 the	
function	 of	 ADP‐ribosylation,	 however	 increased	 levels	 of	 this	 modification	 were	
observed	 upon	 DNA	 damage	 (Hassa	 et	 al.,	 2006).	 The	 last	 10	 years	 of	 extensive	
research	have	linked	ADP	ribosylation	with	DNA	replication	and	transcription	that	go	
far	 beyond	 the	 limited	 role	 in	 genotoxic	 stress	 response	 (Hottiger,	 2011).	 These	
observations	 implicate	 ADP‐ribosylation	 in	 different	 pathologies	 such	 as	 cancer,	
inflammation	and	neurodegenerative	disorders	(Hassa	and	Hottiger,	2008;	Szabo	et	
al.,	2011;	Yelamos	et	al.,	2011). 
A	 critical	 role	 in	 transcription,	 maintenance	 of	 chromatin	 structure	 and	 DNA	
repair	has	emerged	 for	ubiquitination	of	histone	proteins	 (Cao	and	Yan,	2012).	The	
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mono‐ubiquitynated	 histone	 H2A	 at	 lysine	 119	 correlates	 with	 gene	 silencing,	
whereas	 H2BK123	 mono‐ubiquitynation	 was	 shown	 to	 be	 associated	 with	
transcriptional	 initiation	 and	 elongation	 (Bannister	 and	 Kouzarides,	 2011).	
Polyubiquitynation	of	K63	of	histone	H2A	and	H2AX,	a	variant	of	H2A,	has	been	found	
to	 be	 required	 for	 DNA	 repair	 mechanism.	 Several	 studies	 demonstrated	 the	
occurrence	 of	 a	 cross‐talk	 between	 histone	 ubiquitination	 and	 other	 covalent	
modifications.	 For	 example,	mono‐ubiquitination	 of	 H2B	 is	 a	 prerequisite	mark	 for	
methylation	 of	 H3K4	 and	 K27	 and	 that	 H2A	 mono‐ubiquitination	 is	 connected	 to	
H3K36me2	demethylation	(Cao	and	Yan,	2012).	Although	the	precise	mechanism	by	
which	 histone	 ubiquitination	 regulates	 different	 biological	 processes	 is	 poorly	
understood,	 aberrations	 within	 ubiquitination	 or	 deubiquitination	 of	 histones	 are	
clearly	associated	with	multiple	human	diseases	including	cancer,	making	it	a	target	
for	further	investigations	(Johnsen,	2012).	
The	language	of	histone	modifications	has	an	extra	level	of	complexity.	Certain	
covalent	 marks	 can	 inﬂuence	 the	 occurrence	 of	 one	 or	 more	 subsequent	
modiﬁcations	either	in	cis,	on	the	same	histone	molecule,	or	in	trans,	between	histone	
molecules	 or	 across	 nucleosomes.	 The	 final	 biological	 read‐out	 represents	 the	
crosstalk	 between	 distinct	 modifications	 with	 a	 particular	 impact	 on	 chromatin	
organization	and	structure	 (Fischle	et	al.,	2003;	Latham	and	Dent,	2007).	There	are	
several	levels	of	“communication”	between	different	histone	modifications	(Bannister	
and	Kouzarides,	2011):	
I. A	 particular	 residue	 can	 undergo	 multiple	 choices	 of	 post‐translational	
modifications.	For	example	the	lysine	residues	on	histone	proteins	can	be	acetylated,	
mono‐,	 di‐,	 tri‐methylated	 or	mono‐ubiquitynated	 (Fischle	 et	 al.,	 2003;	 Kouzarides,	
2007);	
II. One	covalent	modification	may	depend	upon	a	pre‐existing	mark.	For	instance,	
the	methylation	of	H3K79	and	H3K4	 in	yeast	 is	dependent	on	the	ubiquitynation	of	
H2BK123	(Lee	et	al.,	2007);	
III. The	 affinity	 of	 a	 protein	 to	 a	 specific	 covalent	 mark	 can	 be	 disrupted	 by	 a	
neighbouring	 modification.	 During	 mitosis	 phosphorylation	 of	 H3S10	 disrupts	 the	
binding	of	HP1	to	methylated	H3K9	and	promotes	acetylation	on	K14	in	response	to	
particular	signals	(Lee	et	al.,	2007;	Bannister	and	Kouzarides,	2011);		
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IV. A	modification	 in	 an	 enzyme	 substrate	 can	 affect	 its	 enzymatic	 activity.	 For	
example,	proline	isomerization	regulates	methylation	at	H3K36	and	the	induction	of	
transcription	(Nelson	et	al.,	2006);		
V. The	cross‐talk	between	modifications	can	influence	the	recruitment	of	specific	
factors.	For	instance,	the	affinity	binding	of	a	PHD	finger	domain	containing	protein	to	
H3K4me3	increases	upon	acetylation	of	H3K9	and	H3K14	on	the	same	tail	of	histone	
H3	(Vermeulen	et	al.,	2010).		
Taken	 together,	 histone	 modiﬁcations	 can	 act	 synergistically	 in	 a	 context‐
dependent	manner	 to	 facilitate	 or	 repress	 chromatin‐mediated	 processes.	 A	 major	
challenge	 is	 to	decipher	 the	many	aspects	 that	 regulate	changes	 in	gene	expression	
through	histone	and	chromatin	cross‐talks	(Fischle	et	al.,	2003;	Lee	et	al.,	2010).	
1.3 Histone	acetylation	
One	 of	 the	 most	 studied	 post‐translational	 modifications	 is	 histone	 protein	
acetylation.	 The	 enzymatic	 reaction	 involves	 the	 covalent	 attachment	 of	 an	 acetyl	
group	 from	 acetyl‐CoA	 to	 the	 ɛ‐amino	 group	 of	 a	 lysine	 side	 chain.	 The	 positively	
charged	amino	group	is	neutralized	and	the	interaction	with	the	negative	charges	of	
the	 DNA	 phosphate	 backbone	 is	 blocked.	 It	 represents	 a	 highly	 dynamic	 process	
regulated	by	opposing	action	of	two	families	of	enzymes	‐	histone	acetyltransferases	
(HAT),	 recently	 designated	 as	 lysine	 acetyltransferase	 (KAT),	 and	 histone	
deacetylases	(HDAC)	(Allis	et	al.,	2007;	Munshi	et	al.,	2009;	Bannister	and	Kouzarides,	
2011).		
The	 level	 of	 histone	 acetylation	 is	 correlated	 with	 the	 level	 of	 transcription,	
operating	 as	 a	 hallmark	 of	 actively	 transcribed	 genes	 observed	 predominantly	 at	
promoters	 and	 5′	 ends	 of	 transcribed	 units	 (Choi	 and	 Howe,	 2009).	 Lysine	
acetylation‐dependent	 control	 of	 protein	 stability	 has	 also	 been	 reported.	 It	 has	 a	
direct	 regulatory	 potential	 that	 affects	 the	 turnover	 of	 different	 proteins	 such	 as	
transcription	factors	and	proteins	involved	in	nuclear	functions	(Sadoul	et	al.,	2008).	
Considering	 its	 involvement	 in	essential	 cellular	processes	such	as	gene	expression,	
vascular	 remodelling,	 cell	 differentiation,	 neuronal	 plasticity,	 inflammation	 or	
metabolic	events,	lysine	acetylation	can	be	regarded	as	a	master	regulator	in	cellular	
biology	(Furdas	et	al.,	2012).  
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1.3.1 Histone	acetylation	in	transcription,	DNA	damage	and	repair	
Post‐translational	 modifications	 that	 influence	 gene	 transcription	 can	 be	
classified	in	two	groups:	those	that	regulate	gene	activation	and	those	that	correlate	
with	 gene	 repression.	 As	 a	 general	 model	 it	 was	 suggested	 that	 acetylation,	
phosphorylation	 and	 ubiquitination	 are	 connected	 with	 activation	 while	
ubiquitination,	 sumoylation,	 deamination	 and	 proline	 isomerization	 have	 been	
implicated	 in	 repression.	 However,	 in	 the	 past	 decade	 the	 knowledge	 about	 these	
modifications	has	grown	exponentially	and	it	 is	more	 likely	that	any	given	PTM	has	
the	potential	 to	play	a	role	both	 in	activation	and	repression	of	 transcription	under	
different	conditions.	For	instance,	histone	methylation	can	have	a	positive	effect	when	
is	 observed	 in	 the	 coding	 region	 and	 a	 negative	 effect	 in	 the	 promoter	 region	
(Kouzarides,	2007).	
Gene	 expression	 is	 highly	 regulated	 by	 the	 interplay	 between	 acetylation	 and	
deacetylation	 of	 nucleosomal	 histones	 through	 HAT	 and	 HDAC	 enzymes	 in	 the	
context	 of	 changing	 the	 tightly	 packed	 heterochromatin	 to	 a	 more	 relaxed	
euchromatin	 state	 (Munshi	 et	 al.,	 2009;	 Khan	 and	Khan,	 2010).	 The	 recruitment	 of	
HATs	 or	 HDACs	 to	 active	 transcriptional	 sites	 depends	 on	 different	 types	 of	
transcription	 factors.	 Their	 binding	 can	 enhance	 the	 addition	 of	 other	 factors	 to	
nucleosomal	DNA,	such	as	repressors	or	activators	of	 transcription,	thus	preventing	
or	 triggering	 the	 formation	 of	 the	 RNA	 polymerase	 II	 preinitiation	 complex.	 For	
instance,	 the	 recruitment	 of	 the	 ATP‐dependent	 SWI/SNF	 (SWItch/Sucrose	 Non‐
Fermentable)	 chromatin	 remodelling	 complex	 and	 the	 general	 transcription	 factor	
TFIID	 during	 transcription	 initiation	 requires	 histone	 H4K8	 and	 H3K9/K14	
acetylation	(Agalioti	et	al.,	2002).		
The	 positioning	 of	 HATs	 and	 HDACs	 along	 the	 gene	 is	 highly	 regulated.	 At	
promoter	 regions	 the	 actively	 transcribed	 genes	 are	 marked	 by	 high	 levels	 of	
acetylation.	 In	 contrast,	 along	 the	 coding	 regions	 a	 low	 level	 of	 acetylation	 can	 be	
detected,	 that	may	help	 to	 inhibit	 initiation	of	 transcription	 from	cryptic	 intragenic	
promoters	 (Fukuda	 et	 al.,	 2006).	 This	 might	 suggest	 the	 presence	 of	 demarcation	
regions	 between	 hyper‐	 and	 hypo‐acetylated	 sites.	Mutation	 of	 HAT	 and	HDAC	 not	
only	shifts	the	border	between	functional	regions	of	chromosomes	but	can	alter	the	
segments	of	active	regions	within	a	gene	(Fukuda	et	al.,	2006).	
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In	 the	presence	of	DNA	damage	 the	 recognition	 and	 repair	 of	 the	 lesion	must	
take	 place	 in	 the	 context	 of	 chromatin.	 In	 these	 conditions	 a	more	 relaxed	 state	 is	
essential	 for	 the	 repair	machinery	 to	 access	 the	DNA	breaks.	 Thus,	 ATP‐dependent	
chromatin	 remodelling	 complexes	 and	histone	PTMs	are	 important	 for	 this	process	
and	have	been	associated	with	DNA	repair	(Downs,	2008).	Acetylation	of	histone	H3	
and	 H4	 in	 their	 N‐terminal	 tail	 have	 been	 found	 crucial	 for	 DNA	 repair	 in	 both	
mammalian	and	yeast	cells	 (van	Attikum	and	Gasser,	2005).	Histone	H3	acetylation	
occurs	 before	 and	 after	 double‐strand	 break	 repair.	 The	 acetylation	 of	 H3K14	 and	
H3K23	 promotes	 H2AX	 ubiquitination,	 checkpoint	 activation	 and	 DNA	 repair,	
whereas	H3K56	acetylation	restores	the	chromatin	structure	and	arrests	checkpoint	
activation	(Ikura	et	al.,	2007;	Chen	et	al.,	2008).		
The	transient	acetylation	of	histone	proteins	by	HAT	enzymes	allows	the	repair	
machinery	to	access	the	lesion	and	bind	to	the	chromatin.	Indeed,	a	study	performed	
on	cells	lacking	histone	acetylation	demonstrated	that	the	repair	defect	and	impaired	
loading	 of	 repair	 factors	 was	 rescued	 by	 chromatin	 relaxation	 induced	 through	
chemical	treatment	(chloroquine,	sodium	butyrate	or	hypotonic	conditions)	(Murr	et	
al.,	2006).	The	TIP60	(Tat	interactive	protein	60)	multiprotein	complex	in	mammals,	
NuA4	 (Nucleosome	 acetyltransferase	 of	 histone	 H4),	 SWR1	 (SWI/SNF‐related	
protein)	and	 INO80	(Inositol‐requiring	protein	80	)	 in	yeast	are	responsible	 for	 the	
acetylation	of	several	lysine	residues	(H3K14,	K23,	H4K5,	K8,	K12	and	K14)	following	
a	double	stranded	DNA	break	(Kimura	and	Horikoshi,	1998).	The	mammalian	TIP60	
complex	 contains	 several	 subunits	which	provide	acetylation	and	ATP‐ase	activities	
that	 contribute	 to	 histone	 exchange	 (Doyon	 and	 Cote,	 2004).	 For	 instance,	 in	
Drosophila	melanogaster	 in	 the	 presence	 of	 DNA	 damage	 the	 histone	 variant	 H2Av	
becomes	 rapidly	 phosphorylated	 on	 its	 C‐terminus.	 The	 PTM	 is	 recognized	 by	 the	
TIP60	complex	which	can	acetylate	the	histone	variant	and	mediate	its	exchange	with	
an	unmodified	H2Av	(Kusch	et	al.,	2004).		
The	 tumour	 suppressor	 protein	 p53	 functions	 as	 a	 transcription	 factor	
regulating	 gene	 expression	 in	 response	 to	 DNA	 damage.	 Following	 stress,	 p53	
undergoes	 extensive	 PTMs	 to	 improve	 its	 function	 as	 a	 transcription	 factor	 and	
enable	it	to	control	the	cellular	decisions	(cell	cycle	arrest,	senescence	or	apoptosis).	
The	 tumour	 suppressor	 can	 bind	 to	 DNA	 and	 regulate	 the	 recruitment	 of	 general	
transcription	factors	thus	promoting	transcription	of	target	genes	(Patel	et	al.,	2011).	
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The	 acetylation	 of	 the	 C‐terminal	 end	 of	 p53	 is	 crucial	 for	 its	 activation.	 More	
precisely,	it	enhances	its	DNA‐binding	ability,	nuclear	localization	and	its	function	in	
the	 recruitment	 of	 coactivators	 (Prives	 and	 Manley,	 2001).	 To	 emphasize	 the	
importance	of	 PTMs	 in	 the	p53	 regulatory	mechanism,	 studies	on	mammalian	 cells	
demonstrated	that	in	the	presence	of	HDAC	inhibitors	the	level	of	acetylated	p53	was	
simultaneously	 increased	 and	 promoted	 apoptosis	 or	 senescence	 of	 cancerous	 and	
normal	cells	(Langley	et	al.,	2002).	
1.3.2 The	variety	of	lysine	acetyltransferases	
The	first	lysine	acetyltransferase	was	identified	in	1995	when	a	polypeptide	of	
55	 kDa	 (p55)	 was	 isolated	 from	 macronuclear	 preparation	 of	 Tetrahymena	
thermophilia	and	its	HAT	activity	was	demonstrated	(Brownell	et	al.,	1996a).	The	p55	
enzyme	 proved	 to	 be	 surprisingly	 similar	 in	 amino	 acid	 sequence	 to	 the	 yeast	
transcriptional	 coactivator	 GCN5	 (General	 Control	 Nonderepressible‐5).	 These	
findings	 provided	 the	 first	 confirmation	 for	 a	 direct	 connection	 between	 histone	
acetylation	and	transcription	regulation	(Brownell	et	al.,	1996b).	In	the	past	15	years	
studies	 performed	 on	 different	 organisms	 have	 identified	 a	 significant	 number	 of	
coactivator	 proteins	 that	 possess	 HAT	 activity	 demonstrating	 their	 evolutionary	
conservation	from	yeast	to	humans	(Fukuda	et	al.,	2006).		
According	 to	 their	 localization	 within	 the	 cell,	 HATs	 are	 classified	 in	 two	
different	classes:	type	A‐HATs	and	type	B‐HATs	(Table	1.1).	The	members	of	 type	A	
class	are	found	within	the	nucleus,	often	organized	into	large	multiprotein	complexes	
(Yang	 and	 Seto,	 2007).	 They	 are	 responsible	 for	 the	 acetylation	 of	 histones	 and	
regulating	 the	 chromatin	 assembly	 and	 gene	 transcription	 (Munshi	 et	 al.,	 2009).	
Furthermore,	the	type	A‐HAT	class	can	be	divided	into	five	families	based	on	amino	
acid	sequence	homology	as	well	as	on	the	biochemical	mechanism	of	acetyl	transfer:	
 GNAT	(GCN5‐related	N‐acetyltransferase)	family	members	consist	of	HATs	
with	sequence	and	structure	similar	to	GCN5	(Dyda	et	al.,	2000)	and	can	promote	the	
recruitment	of	transcription	factors	to	the	promoters	(Vetting	et	al.,	2005);	
 MYST	 family,	 including	 the	 founding	members	MOZ,	 Ybf2/Sas3,	 Sas2	 and	
Tip60	 that	 are	 involved	 in	 the	 regulation	 of	 a	 variety	 of	 DNA‐mediated	 reactions	
(Fukuda	et	al.,	2006);	
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 CBP/p300	family	named	after	the	two	human	paralogs	p300	and	CBP	with	
a	 wide	 substrate	 specificity	 for	 histones	 and	 role	 in	 gene	 transcription	 regulation	
(Bannister	and	Kouzarides,	1996;	Ogryzko	et	al.,	1996);	
 Transcriptional	Factors‐related	HATs	family	(Mizzen	et	al.,	1996);	
 Nuclear	Receptor	 coactivator	 families	 (Hodawadekar	 and	 Marmorstein,	
2007;	Furdas	et	al.,	2012).		
The	 type	B‐HAT	class	 is	represented	by	HAT1	(Histone	Acetyltransferase	1),	a	
primarily	 cytoplasmic	 enzyme	 involved	 in	 acetylating	 the	 newly	 synthesized	 free	
histones	prior	their	incorporation	into	replicated	chromatin	(Munshi	et	al.,	2009).		
Most	 lysine	 acetyltransferase	 enzymes	 function	 as	 multisubunit	 complexes.	
These	 complexes	 are	 generally	 comprised	 of	 one	 protein,	 that	 serves	 as	 catalytic	
subunit,	 and	accessory	proteins	which	are	 required	either	 for	 enzymatic	 activity	or	
for	targeting	the	HAT	to	specific	locations	within	the	genome	(Choi	and	Howe,	2009).	
Lysine	acetylation,	in	addition	to	its	role	in	modulating	the	interaction	between	DNA	
and	histones,	 can	act	 as	molecular	 tag	particularly	 recognized	by	 a	 structural	motif	
called	 the	 bromodomain,	 named	 after	 the	Drosophila	 protein	 BRAHMA	 (Yun	 et	 al.,	
2011).	The	evolutionarily	conserved	bromodomain	was	the	first	protein	module	to	be	
shown	to	interact	with	acetylated	lysines	in	the	histone	N‐terminal	tail	(Jenuwein	and	
Allis,	2001).	The	association	of	acetylated	histones	and	bromodomains	maintains	the	
acetylation	 state	 and	 regulates	 the	 activities	 of	 bromodomain‐containing	 factors	
(Fukuda	et	al.,	2006).	Bromodomains	were	identified	in	several	HATs	and	chromatin	
remodelling	 complexes	 as	 well	 in	 general	 transcription	 factors	 with	 important	
functions	in	gene	activation	(Fischle	et	al.,	2003;	Suganuma	and	Workman,	2011).	
1.3.3 The	GNAT	acetyltransferase	family	
Shortly	after	the	yeast	GCN5	protein	was	characterized	as	an	acetyltransferase	
enzyme	 several	 other	 HAT	 proteins	 were	 identified	 and	 classified	 into	 distinct	
families	 (Table	1.1)	 (Roth	et	al.,	2001).	Each	HAT	 family	appears	 to	have	enzymatic	
preferences	 for	 distinct	 substrates	 and	 acting	 in	 different	 functional	 contexts	
(Marmorstein	and	Roth,	2001).	
The	 GCN5‐related	 N‐acetyltransferase	 family	 is	 represented	 by	 class	 A‐HAT	
histone	 acetyltransferase	 GCN5	 and	 by	 class‐B	 histone	 acetyltransferase	 HAT1,	 the	
Elongator	complex	subunit	ELP3	(Elongator	complex	protein	3),	the	PCAF	(p300/CBP	
associated	 factor),	 the	mediator	complex	subunit	NUT1	(Negative	regulation	of	URS	
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Two)	and	HPA2	(Histone	and	other	Protein	Acetyltransferase)	(Table	1.1)	(Selvi	et	al.,	
2010).	According	 to	 their	amino	acid	sequences	 the	members	of	GNAT	family	share	
several	functional	domains:		
 N‐terminal	region	of	variable	length;	
 highly	 conserved	 acetyltransferase	 domain	 important	 for	 acetyl‐CoA	
recognition	and	binding;	
 domain	 that	 interacts	 with	 ADA2	 (Alteration/Deficiency	 in	 Activation	
protein	2)	coactivators,		
 carboxy‐terminal	 bromodomain	 that	 interacts	 with	 acetyl‐lysine	 residues	
(Roth	et	al.,	2001).		
The	ELP3	lysine	acetyltransferase,	member	of	the	GNAT	family,	 is	the	catalytic	
subunit	 of	 the	 Elongator	 complex.	 It	 was	 identiﬁed	 as	 a	 subunit	 of	 a	 multisubunit	
complex	that	co‐puriﬁes	with	the	hyper‐phosphorylated	form	of	the	RNA	polymerase	
II	 holoenzyme	 in	 yeast	 and	 human	 cells	 (Singh	 et	 al.,	 2010).	 The	 ELP3	 protein	 has	
been	described	to	promote	the	acetylation	of	alpha‐tubulin	in	microtubules	of	cortical	
neurons,	 hence	modulating	 the	migration	 and	 differentiation	 of	 projection	 neurons	
during	corticogenesis	(Creppe	et	al.,	2009).	ELP3	can	promote	histone	H3	acetylation	
throughout	the	coding	regions	of	certain	neuronal	cell	motility	genes	in	mammalian	
cells	suggesting	a	role	in	neuronal	gene	regulation	(Close	et	al.,	2006).	Disruption	of	
the	HAT	 activity	 of	 ELP3	 has	 been	 identified	 in	 a	 number	 of	 human	 disorders	 that	
specifically	affect	neuronal	functions	(Singh	et	al.,	2010).	
Several	 functional	 studies	 have	 emphasized	 the	 role	 of	 GNAT	 members	 in	
regulating	 cell	 growth	 and	 development.	 Knockout	 of	 murine	 GCN5	 resulted	 in	
embryonic	lethality	(Bu	et	al.,	2007).	In	yeast,	disruption	of	the	gene	encoding	GCN5	
impaired	normal	progression	 through	 the	G2‐M	phase	of	 the	 cell	 cycle,	 and	mitotic	
gene	 expression	 (Trievel	 et	 al.,	 1999).	 PCAF,	 the	 homologue	 of	 GCN5	 and	 another	
important	 member	 of	 the	 GNAT	 family	 plays	 essential	 role	 in	 transcriptional	
activation,	cell	cycle	arrest	and	cell	differentiation	in	mammalian	cultured	cells	(Selvi	
et	 al.,	 2010).	 In	 young	 adult	mice	 loss	 of	 PCAF	 expression	 resulted	 in	 neurological	
dysfunctions,	including	memory	deficit	and	exaggerated	responses	to	external	stimuli	
(Maurice	 et	 al.,	 2008).	 Studies	 have	 also	 reported	 that	 PCAF	 possesses	 an	 intrinsic	
ubiquitination	 activity	 important	 for	 controlling	 the	 level	 of	 oncoprotein	 HDM2	
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(human	 double	 minute‐2	 protein)	 and,	 consequently,	 influencing	 the	 stability	 and	
activity	of	tumour	suppressor	p53	(Linares	et	al.,	2007).		
Both	enzymes,	GCN5	and	PCAF,	have	been	characterized	as	catalytic	subunits	of	
multiprotein	 SAGA‐type	 (SPT‐ADA‐GCN5	 acetyltransferase)	 complexes	 (Grant	 et	 al.,	
1997;	Nagy	and	Tora,	2007).	Furthermore,	in	humans,	another	multiprotein	complex	
ATAC	 (Ada	 Two	 A	 containing)	 has	 been	 identified	 to	 contain	 GCN5	 or	 PCAF	 as	 its	
catalytic	subunit	(Wang	et	al.,	2008).	
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Table	1.1	Lysine	acetyltransferase	families	and	their	transcription	related	functions	(Torok	and	Grant,	2004;	Fukuda	et	al.,	2006;	Allis	et	al.,	2007).	
Class	 Family	 HAT	 HAT	complex KAT Histone	substrate Function
A	
GNAT	 Gcn5	 SAGA,	SLIK,	SALSA,	
ADA,	HAT‐A2,	ATAC	
KAT2 H3	and	H2B	 Transcription	activation,	DNA	
repair	
Gcn5L	 STAGA,	TFTC KAT2A H3	and	H2B	 Transcription	activation
PCAF	 PCAF KAT2B H3	and	H2B	 Transcription	activation
Elp3	 Elongator KAT9 H3 Transcriptional	elongation
HPA2	 HATB H4 Transcriptional	elongation
Nut1	 Mediator H3,	H4 RNA	Pol	II	transcription
MYST	 Tip60	 NuA4 KAT5 H4,	H2A,	
dH2Av/yHtzl	
Transcription	activation,	DNA	
repair	
Sas3	 NuA3 KAT6 H3 Transcription	activation,	
elongation,	DNA	replication	
MOF/MYST1	 MSL KAT8 H4 Chromatin	boundaries,	dosage	
compensation,	DNA	repair	
MOZ/MYST3	 KAT6A H3 Transcription	activation
MORF/MYST4 KAT6B H3 Transcription	activation
HBOI/MYST2	 KAT7 H4	and	H3	 Transcription,	DNA	replication
p300/CBP	 CBP	 p300/CBP KAT3A H3,	H4,	H2A,	H2B Transcription	activation
p300	 p300/CBP KAT3B H3,	H4,	H2A,	H2B Transcription	activation
TF‐related	
HATs	
TAF1/TBP	 TFIID KAT4 H3,	H4 Transcription	activation
TFIIIC90	 TFIIIC KAT12 H3 RNA	Pol	III	transcription
Nuclear	
receptor	co‐
activators	
SRC‐1	 KAT13A H3,	H4 Transcription	activation
ACTR	 KAT13B H3,	H4 Transcription	activation
P160	 KAT13C H3,	H4 Transcription	activation
CLOCK	 KAT13D H3,	H4 Transcription	activation
B	 GNAT	related	 Hat1	 HAT1/2 KAT1 H4 Histone	deposition,	DNA	repair
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1.4 The	SAGA	and	ATAC	acetyltransferase	complexes	
Homologues	 of	 the	 GCN5	 enzyme	 have	 been	 identified	 as	 the	 catalytic	
component	of	different	multiprotein	HAT	complexes	in	nearly	all	eukaryotes	(Brown	
et	al.,	2000;	Sterner	and	Berger,	2000).	In	yeast,	recombinant	GCN5	could	catalyse	the	
acetylation	of	 free	histones	on	H3	at	K9/K14	and	H4	 at	K8/K16	 (Kuo	 et	 al.,	 1996).	
However,	 in	 the	 context	 of	 the	 nucleosome	 core	 particle	 in	 which	 histones	 exist	
within	chromatin,	recombinant	GCN5	was	not	able	to	acetylate	histone	proteins	(Kuo	
et	al.,	1996).	This	implied	that	other	factors	are	necessary	to	regulate	the	recognition	
of	histone	substrate	or	the	acetyltransferase	activity	of	GCN5	(McCullough	and	Grant,	
2010).	 A	 combination	 of	 in	 vitro	 and	 in	 vivo	 genetic	 and	 biochemical	 studies	 have	
demonstrated	 that	 yeast	GCN5	 can	 functionally	 interact	with	 two	 adaptor	 proteins,	
ADA2	 and	 ADA3.	 Their	 association	 into	 a	 heterotrimeric	 complex	 could	 acetylate	
nucleosomal	 histones	 (Balasubramanian	 et	 al.,	 2002).	 Further	 studies	 led	 to	 the	
identification	and	characterization	of	two	high‐molecular‐mass	HAT	complexes,	SAGA	
and	ADA,	with	 apparent	molecular	masses	of	1.8	 and	0.8	mega	Dalton	 (MDa).	Both	
contain	GCN5	as	catalytic	subunit	and	ADA2	as	adaptor	protein	(Grant	et	al.,	1997).	
The	architecture	and	function	of	yeast	acetyltransferase	complexes	have	served	as	a	
foundation	for	the	identification	and	characterization	of	similar	complexes	in	higher	
eukaryotes	(McCullough	and	Grant,	2010).	
In	contrast	to	yeast,	vertebrates	possess	two	GCN5	isoforms	that	are	believed	to	
originate	 from	alternative	splicing	of	a	single	gene	product	(Smith	et	al.,	1998).	The	
short	isoform	(GCN5S)	is	similar	in	size	and	function	to	the	yeast	GCN5	protein.	The	
higher	 molecular	 weight	 isoform	 (GCN5L)	 is	 predominantly	 expressed	 and	
incorporated	 into	 human	 SAGA	 and	 shows	 high	 similarity	 in	 the	 amino‐terminal	
domain	to	another	GCN5‐related	family	member,	PCAF	(Xu	et	al.,	1998).	The	GCN5L	
isoform	 was	 also	 identified	 in	 Drosophila	 melanogaster	 (dGCN5)	 suggesting	 an	
evolutional	 conservation	 among	 metazoans	 (Smith	 et	 al.,	 1998).	 Moreover,	 during	
evolution	the	yeast	Ada2	gene	diverged	into	two	functionally	distinct	ADA2	paralogs	
in	 the	 animal	 kingdom,	 ADA2‐alpha	 (ADA2a)	 and	 ADA2‐beta	 (ADA2b).	 GCN5	 was	
shown	 to	 interact	with	 both	 ADA2	 proteins	 in	Drosophila	 (Muratoglu	 et	 al.,	 2003),	
mice	(Candau	et	al.,	1996)	and	humans	(Barlev	et	al.,	2003).	Biochemical	purifications	
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have	demonstrated	that	 the	 two	ADA2	proteins	are	present	 in	distinct	multiprotein	
complexes	with	different	lysine	target	specificity.	The	ADA2b	protein	was	found	to	be	
associated	 with	 SAGA‐like	 complexes	 whereas	 ADA2a	 protein	 was	 identified	 as	 a	
subunit	 of	 ATAC	 and	 PCAF	 complexes	 (Kusch	 et	 al.,	 2003;	 Muratoglu	 et	 al.,	 2003;	
Guelman	 et	 al.,	 2006;	 Gamper	 et	 al.,	 2009).	 Characterization	 of	 the	 SAGA	 complex	
showed	 that	 GCN5,	 ADA2	 and	 ADA3	 were	 not	 required	 for	 the	 integrity	 of	 the	
complex,	 rather	 for	 its	 ability	 to	 recognize	 and	 acetylate	 nucleosomal	 substrates	
(Grant	et	al.,	1997).	
SAGA	is	a	large	complex	composed	of	18	to	20	protein	subunits.	It	was	initially	
characterized	 in	 yeast	 and	 is	 highly	 conserved	 throughout	 eukaryotes	 including	
Drosophila	melanogaster	and	mammals	(Table	1.2).	
Table	 1.2	 Subunit	 composition	 of	 SAGA	 and	 ATAC	 complexes	 in	 Saccharomyces	 cerevisiae,	
Drosophila	melanogaster	and	Homo	 sapiens	 (Lee	and	Workman,	2007;	Nagy	and	Tora,	2007;	
Wang	et	al.,	2008;	Nagy	et	al.,	2010).	
Complex	 ySAGA		 dSAGA	 hSTAGA	 dATAC		 hATAC		
Organism	 S.	cerevisiae	 D.	melanogaster	 H.	sapiens	 D.	melanogaster	 H.	sapiens
Catalytic	
subunit	 yGCN5	 dGCN5	 hGCN5	 dGCN5	 hGCN5	
Complex	
subunits	 yTRA1	 dTRA1	 hTRRAP	 	 POLE4	
ySPT7	 dSPT7 hSTAF65γ D12	 YEATS2
ySPT8	 CG30390	
	 ySPT3	 dSPT3	 hSPT3	
dATAC2	
(CG10414)	 hATAC2	
ySPT20	 CG10238	 MBIP
	 yADA1	 dADA1	 hSTAF42	
dATAC1	
(CG9200)	 ZZZ3	
yADA2	 dADA2B hADA2B dADA2A	 hADA2A
yADA3	 dADA3 hSTAF54 dADA3	 hADA3
ySGF29	 dSGF29 hSTAF36 CG30390	 hSGF29
ySGF73	 hATXN7
yUBP8	 hSTAF60
ySGF11	 hSTAF46
yTAF5	 dTAF5 hTAF5L WDS	 WDR5
yTAF6	 dTAF6 hTAF6L MAP3K7
yTAF9	 dTAF9 hTAF9 dATAC3	 UBAP2L
yTAF10	 dTAF10B hTAF10 dNC2β	 hNC2β
yTAF12	 dTAF12 hTAF12 CHRAC14	 POLE3
yCHD1	 hSTAF36
ySUS1	 WDA TBP
dHCF	 hHCF1
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	SAGA	 complex	 can	 be	 divided	 into	 four	 separate	 modules	 based	 on	 genetic,	
biochemical	 and	 structural	 studies	 from	 Saccharomyces	 cerevisiae	 (Weake	 and	
Workman,	2012).		
 The	HAT	module	 contains	GCN5,	ADA2,	ADA3	and	SGF29	 (SAGA‐associated	
factors	 of	 29)	 and	 catalyses	 the	 acetylation	 of	 multiple	 lysine	 residues	 in	
order	 to	make	 the	 chromatin	 accessible	 for	binding	of	 transcription	 factors	
and	the	formation	of	the	preinitiation	complex	(PIC)	(Balasubramanian	et	al.,	
2002).		
 The	 deubiquitinating	 (DUB)	module	 consists	 of	 Ubp8,	 an	 ubiquitin	 specific	
protease	 which	 has	 been	 shown	 to	 associate	 with	 SGF11,	 SGF73	 and	
SUS1	(Sl	gene	 Upstream	 of	 ySa1)	 to	 facilitate	 elongation	 through	
deubiquitination	of	H2B	which	allows	the	recruitment	of	CTK1	(CTD	kinase	
subunit	 alpha)	 kinase	 and	 subsequent	 phosphorylation	 of	 the	 Pol	 II	 C‐
terminal	domain	(Wyce	et	al.,	2007).		
 The	 TAF	 module	 includes	 several	 TATA‐binding	 proteins	 (TBP)‐associated	
factors	that	are	shared	with	TFIID	general	transcription	factor	and	might	play	
an	architectural	role	within	SAGA	(Lee	et	al.,	2011).		
 The	TRA1	module	that	together	with	several	SPT	(SuPpressor	of	Ty)	proteins	
function	 in	 the	 recruitment	 of	 Pol	 II	 and	 preinitiation	 complex	 formation	
(Bhaumik	and	Green,	2001).	
The	ATAC	complex	is	exclusively	present	in	multicellular	eukaryotes	and	absent	
in	yeast	(Table	1.2)	(Barlev	et	al.,	2003;	Muratoglu	et	al.,	2003;	Suganuma	et	al.,	2008).	
Similarly	 to	 SAGA,	 the	 ATAC	 complex	 contains	 a	 HAT	 module	 composed	 of	
GCN5/PCAF	 enzymatic	 subunit	 and	 several	 adaptor	 proteins	 that	 modulate	 the	
catalytic	 activity	 of	 the	 enzymatic	 complex	 (Table	 1.2)	 (Gamper	 et	 al.,	 2009).	
Moreover,	ATAC	harbours	a	secondary	subunit,	ATAC2	with	putative	HAT	functions	
(Suganuma	 et	 al.,	 2008).	In	vivo	 and	 in	 vitro	 Drosophila	 studies	 demonstrated	 the	
existence	 of	 an	 interplay	 between	 dATAC	 and	 chromatin	 remodelling	 complexes.	
Thus,	 a	 mechanism	 might	 be	 proposed	 where	 binding	 of	 ATAC	 to	 the	 chromatin	
depends	 on	 chromatin	 remodelling,	 which	 is	 further	 regulated	 by	 the	 enzymatic	
activity	 of	ATAC	 subunits	 (Carre	 et	 al.,	 2008;	 Suganuma	 et	 al.,	 2008;	 Spedale	 et	 al.,	
2012).	 Additionally,	 in	 pluripotent	 stem	 cells	 ATAC	 was	 found	 to	 form	 a	 stable	
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interaction	 with	 the	 Mediator	 complex,	 an	 important	 intermediary	 between	
activators	and	RNA	Pol	II	(Krebs	et	al.,	2010).	
Genetic	 analysis	 in	 Drosophila	 established	 that	 both	 dGCN5‐containing	
complexes	are	important	during	embryonic	development	(Pankotai	et	al.,	2005;	Carre	
et	al.,	2008),	although,	according	to	DNA	microarray	analysis,	they	regulate	different	
sets	 of	 genes.	 The	 dATAC	 mutation	 affected	 the	 expression	 profile	 of	 40%	 of	 all	
transcripts,	 mostly	 those	 involved	 in	 the	 ecdysone	 transcription	 pathway,	 while	
alteration	 of	 dSAGA	 function	 affected	 only	 3%	 of	 the	 transcripts	 including	 those	
involved	 in	antimicrobial	defence	mechanism	(Zsindely	et	al.,	2009).	Recent	 studies	
on	 the	binding	profile	of	human	ATAC	and	SAGA	have	 indicated	 that	while	ATAC	 is	
able	 to	 bind	 to	 three	 distinct	 locations	 on	 the	 chromatin,	 known	 enhancers,	
transcription	start	sites	(TSS)	and	at	distal	 loci	not	marked	by	previously	described	
enhancer	features	(H3K4me1,	DHSs,	Pol	II),	SAGA	can	only	bind	to	known	enhancers	
and	TSSs	(Krebs	et	al.,	2011).		
1.4.1 ADA2	coactivator	proteins	
Genetic	 studies	 in	 Saccharomyces	 cerevisiae	 have	 been	 essential	 for	 the	
discovery	 of	 several	 Ada	 genes	 as	 cofactor	 proteins	 involved	 in	 eukaryotic	
transcription.	 The	 ADA2	 proteins	 have	 been	 reported	 to	 play	 an	 important	 role	 in	
transcriptional	 initiation	site	selection,	they	interact	with	basal	transcription	factors	
and	 potentiate	 the	 HAT	 activity	 of	 GCN5	 (Berger	 et	 al.,	 1992;	 Barlev	 et	 al.,	 1995;	
Balasubramanian	 et	 al.,	 2002;	 Barlev	 et	 al.,	 2003).	 In	 contrast	with	 the	 single	Ada2	
gene	 characterized	 in	 yeast,	 in	metazoan	 organisms	 (including	mouse	 and	 human)	
and	 Arabidopsis	 thaliana,	 there	 are	 two	 genes	 encoding	 Ada2‐type	 coactivators	
(Candau	et	al.,	1996;	Stockinger	et	al.,	2001).	In	Arabidopsis	thaliana	the	Ada2b	gene	
is	 involved	 in	 abiotic	 stress	 response	 by	 controlling	 histone	 acetylation	 in	 the	
presence	 of	 salt	 stress	 or	 by	 regulation	 of	 the	 nucleosome	 occupancy	 in	 low	
temperature	response	(Vlachonasios	et	al.,	2011).	
Functional	differences	between	the	two	human	ADA2	proteins,	ADA2‐alpha	and	
ADA2‐beta,	have	been	reported	(Barlev	et	al.,	2003).	ADA2‐alpha	was	 found	to	be	a	
stable	 component	 of	 the	 human	 PCAF	 complex	 (Ogryzko	 et	 al.,	 1998).	 In	 contrast,	
ADA2‐beta	 appeared	 not	 to	 be	 a	 stable	 component	 of	 PCAF‐	 or	 GCN5‐containing	
macromolecular	complexes,	but	interacted	with	subunits	of	the	SWI/SNF	chromatin‐
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remodelling	 complex	 (Barlev	 et	 al.,	 2003)	 and	 enhanced	 the	 acetylation	 of	
nucleosomes	by	GCN5L	(Gamper	et	al.,	2009).	
The	 Drosophila	 genome	 also	 comprises	 of	 two	 dAda2	 genes	 encoding	 two	
adaptor	 proteins	 referred	 to	 as	 dADA2a	 and	 dADA2b.	 Studies	 have	 demonstrated	
their	 essential	 roles	 during	 development	 as	 subunits	 of	 two	 functionally	 and	
structurally	 distinct	 multiprotein	 complexes	 (Kusch	 et	 al.,	 2003;	 Muratoglu	 et	 al.,	
2003;	 Qi	 et	 al.,	 2004).	 dADA2b	 is	 found	 in	 the	 2	 MDa	Drosophila	 dSAGA	 complex,	
while	 dADA2a	 is	 associated	 with	 dATAC,	 a	 0.8	 MDa	 complex	 (Kusch	 et	 al.,	 2003;	
Guelman	et	al.,	2006).	Gene	characterization	showed	that	through	alternative	splicing	
the	dAda2a	gene	directs	the	synthesis	of	not	only	the	dADA2a	protein	but	that	of	the	
RNA	Pol	II	subunit	RPB4	as	well.	In	the	same	manner,	the	dAda2b	gene	encodes	two	
protein	isoforms,	dADA2bS	and	dADA2bL,	identical	in	their	N‐terminal	but	distinct	in	
their	C‐terminal	regions	(Muratoglu	et	al.,	2003).	
In	Drosophila	the	dAda2a	and	dAda2b	genes	are	located	on	the	3rd	chromosome	
in	 the	 90F10	 and	 84F5	 cytological	 region.	 The	 two	 dADA2	 proteins	 are	 similar	 in	
containing	a	ZZ	domain	 in	 their	N	terminal	region,	 followed	by	a	SANT	domain	and	
two	 or	 three	 less	 conserved	 regions	 designated	 as	 ADA	 boxes	 (Kusch	 et	 al.,	 2003;	
Muratoglu	 et	 al.,	 2003).	 Similar	 structural	 organization	 for	ADA2	 is	 recognizable	 in	
most	metazoans.	The	ZZ	is	a	putative	zinc‐binding	domain,	the	SANT	is	a	DNA‐binding	
domain	and	the	function	of	ADA	boxes	is	unknown.	Recently,	the	last	of	the	three	ADA	
boxes	of	human	ADA2‐alpha	has	been	identified	as	a	SWIRM	domain,	a	structural	unit	
supposed	 to	 bear	 chromatin	 binding	 function	 (Qian	 et	 al.,	 2005;	 Yoneyama	 et	 al.,	
2007).	Significantly,	the	four	α‐helices	constituting	the	SWIRM	domain	in	most	ADA2	
proteins	 can	 be	 identified	 in	 the	 C‐terminal	 region	 of	 only	 one	 of	 the	 two	 dADA2	
proteins	(Yoneyama	et	al.,	2007). 
Although	 the	 similarity	 between	 the	 two	 dADA2	 proteins	 in	 their	 N‐terminal	
halves	 is	 over	 50%	 (Kusch	 et	 al.,	 2003;	 Muratoglu	 et	 al.,	 2003),	 they	 participate	
strictly	in	distinct	complexes	and	are	not	able	to	functionally	substitute	for	each	other	
(Pankotai	 et	 al.,	 2005).	 Null	 mutations	 of	 dAda2b	 (ada2bd842)	 interfere	 with	 the	
function	 of	 dSAGA	 and	 result	 in	 decreased	 histone	 H3K9ac	 and	 H3K14ac	 levels	 in	
vivo,	 as	 clearly	 observable	 on	 antibody	 stained	 polytene	 chromosomes	 of	 mutant	
larvae	 (Qi	 et	 al.,	 2004;	 Pankotai	 et	 al.,	 2005).	 On	 the	 other	 hand,	 the	 dAda2a	 null	
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mutation	(ada2ad189)	abolished	the	K5	and	K12	acetylation	of	H4	while	displaying	no	
significant	change	in	K9	and	K14	acetylation	of	histone	H3	(Ciurciu	et	al.,	2006).		
Overall,	 the	ADA2	coactivator	proteins	 together	with	other	components	of	 the	
histone	 acetyltransferase	 complexes	 are	 major	 determinants	 in	 specifying	 the	
substrate	preference	as	well	as	the	gene‐specific	targeting	of	these	complexes.	
1.5 Histone	modifications	and	diseases	
Histone	modifications	 are	 known	 to	 regulate	different	physiological	 processes	
including	 transcription,	 replication,	 DNA	 repair	 and	 cell	 cycle	 progression	
(Ehrenhofer‐Murray,	2004;	Groth	et	al.,	2007;	Kouzarides,	2007).	Thus,	misregulation	
of	the	activity	of	the	histone	modifying	enzymes	can	result	in	altered	gene	expression	
patterns	that	can	lead	to	many	human	diseases,	including	cancer.		
Although	cancer	is	fundamentally	a	genetic	disease,	increasing	evidence	indicate	
that	 covalent	 histone	 modifications	 are	 globally	 and	 locally	 altered	 in	 cancer	
epigenomes	 (Jones	 and	 Baylin,	 2007).	 The	 global	 reduction	 of	 H4K16ac	 and	
H4K20me3	has	been	associated	with	breast	and	liver	cancer	(Bhaumik	et	al.,	2007).	
Decrease	 of	 H4K16	 acetylation	 correlates	 with	 an	 increased	 genomic	 instability	
facilitating	 mutations	 and	 chromosomal	 rearrangements	 that	 might	 progress	 to	
cancer	(Lennartsson	and	Ekwall,	2009).	Mice	deficient	for	the	SUV39	(suppressor	of	
variegation	 3‐9)	 H3K9	 methyltransferase	 demonstrated	 reduced	 levels	 of	
heterochromatic	 H3K9me2/3	 with	 severely	 impaired	 viability	 and	 chromosomal	
instabilities	 plus	 an	 increased	 risk	 of	 developing	 cancer	 (Peters	 et	 al.,	 2001).	
Mutations	 of	 certain	 HATs	 can	 also	 cause	 cancer	 as	 observed	 in	mice	 (Kung	 et	 al.,	
2000)	 as	 well	 as	 in	 several	 cases	 of	 human	 leukaemia	 (Shigeno	 et	 al.,	 2004).	 At	
present,	 a	 promising	 therapeutic	 potential	 to	 reverse	 abnormal	 epigenetic	 changes	
associated	with	cancer	is	based	on	the	administration	of	HDAC	inhibitors.	Studies	in	
cell	 culture	 and	 animal	models	 have	 shown	 that	 inhibition	 of	 histone	 deacetylases	
induces	proliferation	arrest,	differentiation	and	apoptosis	of	cancer	cells	(Marks	et	al.,	
2000;	Vigushin	and	Coombes,	2002).		
In	 several	 neurodegenerative	 disorders	 such	 as	 Huntington’s,	 Parkinson’s,	
Alzheimer’s	 diseases	 and	 amyotrophic	 lateral	 sclerosis	 altered	 levels	 of	 histone	
acetylation	 have	 been	 observed	 (Selvi	 et	 al.,	 2010).	 In	 vitro	 studies	 on	 cultured	
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cerebellar	primary	neurons	have	reported	increased	deacetylation	of	histone	H3	and	
H4	that	precede	neuronal	death	(Rouaux	et	al.,	2003).	Numerous	studies	suggest	the	
use	 of	 several	 HDAC	 inhibitors	 to	 restore	 histone	 acetylation	 and	 transcriptional	
activation	in	different	neurodegenerative	disease	models	(Selvi	et	al.,	2010).		
Histone	 covalent	 modifications	 are	 also	 important	 for	 the	 control	 of	 learning	
and	 memory	 functions.	 In	 mice,	 loss	 of	 PCAF	 function	 correlated	 with	 decreased	
learning	 competence	 and	 increased	 stress	 response	 (Maurice	 et	 al.,	 2008). The 
Rubinstein‐Taybi	syndrome	is	an	autosomal	dominant	disorder	associated	 in	~55%	
of	cases	with	mutations	in	CREB	binding	protein	(CBP)	(Petrij	et	al.,	1995).		
Although	 little	 is	 known	 about	 the	 implication	 of	 covalent	 modifications	 in	
autoimmune	diseases	recent	studies	have	described	a	role	for	histone	modifications	
in	 rheumatoid	 arthritis.	 It	 is	 a	 chronic	 disease	 characterized	 by	 systemic	
inflammation,	 joint	 destruction,	 disability	 and	 pain	 (Klein	 and	 Gay,	 2013).	 The	
transcription	 factor	 NF‐κB	 ‐	 a	 key	 inflammatory	 regulator	 ‐	 binds	 very	 poorly	 to	
nucleosomal	 DNA.	 Different	 histone	 modifications	 like	 histone	 H3K9	 and	 S10	
phosphoacetylation,	 reduction	 in	 H3K9me	 and	 increase	 in	 H3/H4	 acetylation,	 are	
needed	to	allow	efficient	NF‐κB	binding	to	 its	 targets.	Thus,	 in	rheumatoid	arthritis,	
the	 reduced	 activity	 of	HDACs	 plays	 a	 key	 role	 in	 regulating	NF‐κB–mediated	 gene	
expression. Although	 treatments	 for	 rheumatoid	 arthritis	 with	 HDAC	 inhibitors	 in	
different	animal	models	have	shown	promising	results	(Nishida	et	al.,	2004;	Lin	et	al.,	
2007;	 Joosten	 et	 al.,	 2011),	 the	 used	 inhibitors	 lack	 specificity	 for	 a	 single	 HDAC	
isoform	and	the	mechanisms	of	action	remains	unknown	(Klein	and	Gay,	2013).	
Elucidating	 the	 role	 of	 HATs	 and	 HDACs	 in	 orchestrating	 proper	 cellular	
development	 and	 differentiation	 will	 enable	 the	 therapeutic	 usage	 of	 modulators	
aimed	at	preserving	 the	physiological	equilibrium	of	acetylation	 (Arrowsmith	et	al.,	
2012).	
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 	Chapter 2.
Aims	
In	 Drosophila	 melanogaster	 dADA2a	 and	 dADA2b	 proteins	 are	 subunits	 of	
dATAC	and	dSAGA	HAT	complexes,	respectively.	Despite	the	fact	that	the	two	dADA2	
proteins	contain	similar	conserved	domains	and	 interact	with	similar	partners	 they	
function	 in	 distinct	 HAT	 complexes.	 These	 observations	 made	 us	 interested	 in	
determining	what	particular	domain	within	dADA2	proteins	 is	 responsible	 for	 their	
interaction	 with	 different	 transcriptional	 coactivators	 and	 the	 GCN5	
acetyltransferase.	 The	 regions	 that	 specify	 the	 association	 of	 dADA2a	 and	 dADA2b	
proteins	to	one	or	the	other	HAT	complexes	were	investigated	by:	
 Constructing	transgenes	that	direct	the	expression	of	chimeric	dADA2a/2b	or	
dADA2b/2a	proteins;		
 Assessing	 their	 in	 vivo	 function	 by	 expressing	 the	 chimeric	 proteins	
in	D.	melanogaster	ada2ad189	or	ada2bd842	mutants;	
 Determining	 the	 histone	 acetylation	 pattern	 on	 polytene	 chromosomes	 of	
both	of	the	ada2	null	animals	expressing	the	chimeric	transgenes;		
 Comparing	 the	 expression	 patterns	 of	 selected	 genes	 from	 ada2ad189	 or	
ada2bd842	null	mutants	to	those	expressing	the	chimeric	proteins.	
Furthermore,	 two	dADA2b	protein	 isoforms	have	been	reported	 in	Drosophila	
melanogaster	 which	 might	 extend	 the	 functional	 complexity	 of	 dSAGA.	 The	 two	
dADA2b	isoforms	are	identical	at	the	N‐terminal	region	but	differ	in	their	C‐terminus.	
Both	isoforms	contain	a	Zinc	finger	and	a	SANT	domain	in	their	N‐terminal	region	and	
two	 ADA	 boxes.	 Only	 the	 long	 dADA2b	 isoform	 contains	 a	 third	 ADA	 box	 in	 its	 C‐
terminal	part.	These	observations	made	us	interested	to	investigate	whether	the	two	
isoforms	are	subunits	of	the	same	HAT	complex	or	there	are	distinct	HAT	complexes	
with	different	dADA2b	isoforms.		
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 	Chapter 3.
Materials	and	methods	
3.1 Molecular	cloning		
3.1.1 Generation	of	chimeric	DNA	sequences	
To	generate	plasmid	constructs	suitable	for	the	expression	of	dADA2a,	dADA2b	
(short	 isoform)	 and	 their	 chimeras	 in	Drosophila	 S2	 cells,	 and	 for	 the	 insertion	 of	
these	 transgenes	 in	 targeted	 landing	 sites	 in	 the	 D.	 melanogaster	 genome,	 we	
obtained	 the	 coding	 sequences	 of	dAda2b	 and	dAda2a	 from	previously	 constructed	
pBTM‐dADA2	plasmids	(Le	Douarin	et	al.,	2001;	Muratoglu	et	al.,	2003).	The	coding	
regions	were	released	by	EcoRI‐SalI	digestions	and	reinserted	into	EcoRI‐XhoI	sites	of	
pENTR3C	 vector	 (Invitrogen)	 generating	 pENTR3C‐dAda2a	 and	 pENTR3C‐dAda2b,	
which	 made	 possible	 the	 use	 of	 the	 Gateway	 cloning	 system	 (Gateway	 system,	
Invitrogen).	This	technology	ensures	fast,	efficient	directional	cloning	where	the	gene	
of	interest	is	excised	from	the	Entry	clone	and	integrated	into	the	Destination	vector	
suitable	for	gene	expression	(Fig.	3.1).	
 
Fig.	 3.1	 Overview	 of	 the	 Gateway	 technique.	 During	 LR	 reaction	 Entry	 clone	 with	 attL	
recombines	with	a	Destination	vector	with	attR	to	form	a	new	expression	clone	with	attB	and	a	
by‐product	with	attP.	The	BP	reaction	is	used	to	create	an	Entry	Clone	from	Expression	Clones	or	
PCR	products.	Image	adapted	from	http://www.invitrogen.com	
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For	 generating	 dAda2bS2a,	 dAda2bM2a	 and	 dAda2bL2a	 chimeric	 constructs,	
fragments	 corresponding	 to	 different	 sizes	 of	 the	 dAda2b	 N‐terminal	 regions	 were	
amplified	by	PCR	using	pENTR3C‐dAda2b	 as	 template	with	oligonucleotide	primers	
which	 introduced	a	BamHI	 site.	At	 the	same	time,	 the	pENTR3C‐dAda2a	 vector	was	
digested	 with	 BamHI	 which	 removed	 a	 791	 bp	 fragment	 corresponding	 to	 the	 N‐
terminal	region	of	dAda2a.	The	digestion	fragments	were	separated,	according	to	size,	
in	 agarose	 gel	 using	 electrophoresis.	 The	 fragments	 desired	 for	 ligation	were	 then	
extracted	using	QIAquick	Gel	Extraction	Kit	(Qiagen).	To	ligate	the	dAda2bS,	dAda2bM	
and	 dAda2bL	 DNA	 fragments	 into	 the	 pENTR3C‐dAda2a	 vector	 T4	 DNA	 Ligase	
(Promega)	was	used	according	to	the	manufacturer’s	instructions.		
A	 similar	 strategy	 was	 performed	 to	 generate	 dAda2a2b	 chimeric	 DNA	 by	
exchanging	 the	 C‐terminus	 of	 pENTR3C‐dAda2a	 (removed	 after	 SpeI	 and	 XhoI	
digestion)	 with	 amplified	 903	 bp	 sequence	 of	 dAda2b.	 The	 C‐terminal	 region	 of	
dAda2b	was	amplified	using	pENTR3C‐dAda2b	as	PCR	template	with	dAda2bFw	and	
dAda2bRv	oligonucleotide	primers	(Table	3.1)	which	introduced	SpeI	and	XhoI	sites.		
Table	3.1	Primer	sequences	used	in	this	study	
Construct		 Primer	symbol	
Primers
Amplicon	
size	(bp)	
Amplicon	
aa	region	Sequence	5′‐3′**	 Restriction	site	
dAda2bS	
pENTR3C	
Fw*	
CTGATAGTGACCTGTT
CGTTGCAA	 ‐	 486	 1‐144	dAda2bS	
Rv	
GTCTGGATCCGTGCCA
TTTACAAA	 BamHI	
dAda2bM	 dAda2bM	Rv	
ATCTGGATCCAAGGTA
GAGAGAGC	 BamHI	 594	 1‐181	
dAda2bL	 dAda2bL	Rv	
GATTGGATCCAGCTTA
AGCATCAC	 BamHI	 750	 1‐233	
dAda2a2b	
dAda2b	
Fw	
GGACTAGTAAATGGCA
CGATTGGAAGGGCC	 SpeI	 903	 118‐418	
dAda2b	Rv	 GACCTCGAGCTATCCAAGTAGTTTTTGCTG	 XhoI	
dAda2bL	
isoform	
AbNCO	 CCATATGGCCATGGCAAG	 NcoI	 700	
	
AbRIBH	 CATGGATCCGAATTCAGTGGCTCAGCCAGC	 BamHI	 	
*The	pENTR3C	Fw	primer	was	used	to	generate	dAda2bM	and	dAda2bL	PCR	fragments	as	well	
**Restriction	sites	used	for	cloning	steps	are	underlined		
***aa	represents	amino	acid	
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The	 chimeric	 constructs	 and	 the	 corresponding	 controls	 were	 transferred	 to	
pAFW	or	pAHW	containing	N‐terminal	FLAG	or	HA	tag,	by	site‐specific	recombination	
according	to	the	manufacturer	protocol	(Gateway	system,	Invitrogen).	
3.1.2 Constructs	for	co‐immunoprecipitation	
The	 two	 dAda2b	 isoforms	 have	 the	 same	 5′	 and	 middle	 coding	 region.	 To	
generate	 dAda2bL	 (dAda2b	 long	 isoform)	 constructs	 suitable	 for	 transient	
transfection	in	S2	cells,	the	3′	region	was	generated	by	PCR	from	a	Drosophila	pACT2	
library	 using	 AbNCO‐AbRIBH	 primer	 pairs	 (Table	 3.1)	 (Pankotai	 et	 al.,	 2005).	 To	
generate	pBTM‐dAda2bL	the	corresponding	PCR	fragment	was	ligated	into	the	NcoI‐
BamHI	sites	of	the	pBTM‐dAda2bS	vector	(Muratoglu	et	al.,	2003).	The	obtained	full‐
length	coding	region	of	dAda2bL	was	further	digested	from	pBTM	with	EcoRI‐SalI	and	
the	fragment	was	ligated	into	EcoRI‐XhoI	sites	of	pENTR3C	Gateway	vector.	Following	
an	 LR	 reaction	 as	 described	 in	 3.1.1	 dAda2bL	 was	 introduced	 into	 pAFW	 vector	
containing	an	N‐terminal	FLAG	tag.	
For	 generation	 of	 N‐terminal	 HA	 tagged	 dADA3	 the	 corresponding	 coding	
sequence	 was	 subcloned	 from	 a	 previously	 described	 pBTM‐dAda3	 plasmid	
(Muratoglu	 et	 al.,	 2003)	 into	 pENTR3C	 by	 digesting	 of	 both	 vectors	 with	 EcoRI	
followed	by	ligation	of	dAda3	to	pENTR3C.	The	obtained	Entry	clone	was	recombined	
into	pAHW	destination	vector	according	to	the	Gateway	Technology	protocol.	Cloning	
of	the	Drosophila	p53	into	pAHW	vector	suitable	for	transient	S2	cell	transfection	was	
previously	described	(Pardi	et	al.,	2011).	
All	 cloned	DNA	 vectors	were	 sequenced	 to	 confirm	 fragments	 as	 being	 in	 the	
correct	orientation	and	in‐frame.	
3.2 Drosophila	S2	cell	transient	transfection	
The	S2	cell	 line	derives	from	a	primary	culture	of	 late	stage	(20‐24	hours	old)	
Drosophila	melanogaster	 embryos	 (Schneider,	 1972).	 Cells	were	 cultured	 at	 25°C	 in	
Schneider’s	Drosophila	 Medium	 (Sigma)	 supplemented	with	 10%	FBS	 (fetal	 bovine	
serum,	 Sigma)	 and	 antibiotics	 (50	 U	 of	 penicillin/ml,	 100	 U	 of	 streptomycin/ml).	
Every	two	days	the	cells	were	split	when	they	had	reached	80%	confluence.		
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For	transient	transfection	about	4106	cells	were	seeded	into	a	60	mm	culture	
dish	 containing	 5	ml	 of	 culture	medium.	 The	 next	 day	 cells	were	 transfected	 using	
Effectene	Transfection	Reagent	(Qiagen)	according	to	the	manufacturer’s	protocol.		
3.3 Co‐immunoprecipitation		
3.3.1 Purification	of	proteins	expressed	in	S2	cells		
Transfection	 of	 S2	 cells	 was	 performed	 as	 described	 above.	 After	 48	 h,	 cells	
were	harvested	by	 centrifugation	 (2000	 rpm,	5	min),	washed	with	1	ml	 of	 ice‐cold	
PBS	and	incubated	in	sonication	buffer	(50	mM	TRIS‐HCl	pH	7.9,	2	mM	EDTA,	50	mM	
NaCl, 0.1	mM	PMSF,	0.1	mM	aprotinin	and	0.1	mM	leupeptin)	for	30	min	on	ice.		
For	 co‐immunoprecipitation	 the	 cells	 were	 lysed	 with	 0.5	 ml	 of	 RIPA	 buffer	
[10	mM	Tris‐HCl	(pH	7.5),	150	mM	NaCl,	1	mM	EDTA,	1%	NP‐40,	0.5%	SDS,	0.1	mM	
PMSF,	0.1	mM	aprotinin	and	0.1	mM	leupeptin]	for	30	min	on	ice.	The	reaction	tubes	
were	 centrifuged	 (13000	 rpm,	 10	 min,	 4°C),	 the	 pellet	 was	 discarded	 and	 the	
supernatant	was	frozen	at	‐80°C	for	further	use.		
3.3.2 Co‐immunoprecipitation	of	proteins		
The	clarified	cell	 lysate	was	incubated	with	20	µl	anti‐FLAG	M2‐agarose	beads	
(Sigma)	 overnight	 at	 4°C	 following	 the	 manufacturer’s	 instructions.	 The	
immunoprecipitates	were	washed	five	times	(4°C,	10	min)	with	TBST	buffer	[50	mM	
Tris‐HCl	(pH	7.5),	400	mM	NaCl,	1%	TWEEN	20]	on	gentle	rotation	and	co‐purified	
proteins	were	 eluted	 from	 the	 beads	 in	 2	 sodium	 dodecyl	 sulphate	 (SDS)	 loading	
buffer	for	5	min	at	95°C.		
3.4 Western	blotting	
For	immunological	detection	of	the	hybrid	proteins,	transiently	transfected	cells	
were	 harvested	 and	 protein	 extraction	 was	 performed	 as	 described	 at	 3.3.1.	 The	
protein	concentrations	were	measured	using	Bradford	reagent	and	20‐25	μg	protein	
was	 separated	 on	 10%	 SDS‐PAGE	 and	 transferred	 by	 electroblotting	 to	 0.4	 μm	
nitrocellulose	membrane.	 The	membranes	were	 blocked	 for	 1	 h	 in	 5%	 dry	milk	 in	
TBST	 (20	 mM	 Tris‐HCl,	 pH	 7.4,	 150	 mM	 NaCl,	 0.05%	 Tween	 20)	 and	 incubated	
overnight	with	primary	antibody	diluted	in	TBST	with	2%	BSA.	For	the	detection	of	
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hybrid	 proteins	M2	 anti‐FLAG	 antibody	 (Sigma)	 in	 1:10000	 dilution	was	 used.	 The	
same	membrane	was	washed	4	for	10	min	in	TBST	and	reprobed	with	anti‐Tubulin	
monoclonal	antibody	(Sigma)	at	1:5000	dilution.		
To	 compare	 histone	 H3,	 H3K14ac	 and	 H4K12ac	 levels,	 total	 protein	 extracts	
were	 prepared	 from	 10	 third	 instar	 larvae	 of	 the	 gcn5E333st	 and	 w1118	 genotype,	
crushed	 in	 sonication	 buffer	 containing	 1mM	 DTT,	 and	 protease	 inhibitor	 mix	
(0.1	mM	 PMSF,	 0.1	 mM	 aprotinin	 and	 0.1	 mM	 leupeptin)	 and	 cleared	 by	
centrifugation	 (5	 min	 13000	 rpm).	 Protein	 concentration	 was	 determined	 by	
Bradford	assay	and	equal	amounts	of	protein	samples	were	loaded	on	15%	SDS‐PAGE	
and	 transferred	 by	 electroblotting	 to	 0.2	 μm	 nitrocellulose	 membrane.	 For	
immunoblotting	 specific	 commercially	 available	 antibodies	 were	 used	 at	 the	
following	dilutions:	H3	(Abcam,	ab1791)	1:5000,	H3K14ac	(Upstate,	06‐911)	1:5000	
and	H4K12ac	(Abcam,	ab1761)	1:1000.	
For	 the	 detection	 of	 co‐immunoprecipitated	 proteins	 the	 following	 primary	
antibodies	 were	 used:	 Anti‐HA	 tag	 antibody	 (Abcam,	 ab9110)	 in	 1:5000	 dilution,	
monoclonal	Anti‐FLAG	M2	antibody	(Sigma,	F1804)	in	1:10000	dilution.	Membranes	
were	 washed	 in	 TBST,	 incubated	 with	 anti‐rabbit‐HRP	 (DACO,	 P0448)	 and	 anti‐
mouse‐HRP	 (DACO,	 P0260)	 secondary	 antibodies,	 washed	 again	 extensively	 and	
developed	using	the	ECL	(Millipore)	following	the	manufacturer’s	recommendations.		
3.5 Drosophila	genetic	analysis	
3.5.1 Fly	husbandry	
All	 flies	 were	 normally	 raised	 on	 standard	 Drosophila	 medium	 at	 25°C	
(Ashburner,	1989).	Flies	were	subsequently	transferred	to	fresh	vials	approximately	
every	two	days.		
3.5.2 Drosophila	collection	
The	 ada2ad189	 and	 ada2bd842	 null	 alleles	 have	 been	 previously	 described	
(Komonyi	 et	 al.,	 2005;	 Pankotai	 et	 al.,	 2005;	Papai	 et	 al.,	 2005).	 The	mutant	 alleles	
were	kept	over	TM6C,	Tb	Sb	balancer	and	homozygotes	were	selected	on	the	basis	of	
Tb+	 phenotype.	 The	 phiX51D	 line with	 the	 following	 genotype	 M[vas‐int.Dm]ZH‐
2A;M[3P3‐RFP.attP]ZH‐51D,	containing	a	ɸC31	integrase	source	and	an	attP	docking	
site,	 were	 kindly	 provided	 by	 Konrad	 Basler	 (University	 of	 Zurich,	 Switzerland)	
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(Bischof	et	al.,	2007).	The	w1118	strain	was	used	as	control	(Ryder	et	al.,	2004).	Other	
stocks	used	in	this	study	were	obtained	from	Szeged	and	Bloomington	Stock	Centres,	
unless	otherwise	indicated.		
3.5.3 Generation	of	transgenic	Drosophila	lines		
All	crosses	were	performed	at	25°C.	The	transgenic	lines	used	in	this	study	are	
described	in	Table	3.2.	
Table	3.2	Genotype	and	the	number	of	analysed	animals. 
Genotype	 No.	of	analysed	
animals	
w/w;	P[dADA2b]/P[act‐Gal4];	ada2ad189/ada2ad189 (control) 150	
w/w;	P[dADA2b]/P[act‐Gal4]; ada2bd842/ada2bd842 (control) 155	
w/w;	P[dADA2a]/P[act‐Gal4]; ada2ad189/ada2ad189 (control) 135	
w/w;	P[dADA2a]/P[act‐Gal4]; ada2bd842/ada2bd842 (control) 87	
w/w;	P[dADA2bS2a]/P[act‐Gal4]; ada2ad189/ada2ad189 197	
w/w;	P[dADA2bM2a]/P[act‐Gal4]; ada2ad189/ada2ad189 241	
w/w;	P[dADA2bL2a]/P[act‐Gal4]; ada2ad189/ada2ad189 228	
w/w;	P[dADA2a2b]/P[act‐Gal4]; ada2ad189/ada2ad189 175	
w/w;	P[dADA2bS2a]/P[act‐Gal4]; ada2bd842/ada2bd842 179	
w/w;	P[dADA2bM2a]/P[act‐Gal4]; ada2bd842/ada2bd842 167	
w/w;	P[dADA2bL2a]/P[act‐Gal4]; ada2bd842/ada2bd842 113	
w/w;	P[dADA2a2b]/P[act‐Gal4]; ada2bd842/ada2bd842 85	
For	 the	 generation	 of	 the	 transgenic	 lines	 expressing	 chimeric	 proteins,	 the	
amplified	DNA	fragments	encoding	chimeric	proteins	were	first	cloned	into	pENTR3C	
vector	(Gateway	Technology,	Invitrogen)	as	described	in	3.1.1.	Following	LR	reaction	
the	 chimeric	 genes	 were	 introduced	 into	 a	modified	 pTWF	 plasmid	 contacting	 the	
360	bp	 attB	 sequence	 (pTWF‐attB).	 The	 Gateway	 vector	 containing	 chimeric	
transgenes	were	 injected	 into	phiX51D	 embryos	 and	 the	 site‐specific	 insertion	 into	
Drosophila	 genome	 was	 mediated	 by	 ɸC31	 integrase.	 Since	 the	 pTWF‐attB	 vector	
enables	 the	 fusion	 of	 a	 FLAG	 tag	 to	 the	 3′	 end	 of	 the	 expressed	 protein,	 the	 DNA	
sequences	of	the	chimeric	transgenes	and	the	corresponding	controls	included	a	stop	
codon	sequence	at	the	C‐terminal.	Thus,	untagged	native	proteins	could	be	expressed.		
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The	transgenic	lines	were	kept	as	homozygotes	on	the	second	chromosome.	To	
analyse	 the	 rescue	 capability	 of	 the	 hybrid	 transgenes	 in	 ada2ad189	 or	 ada2bd842	
mutant	backgrounds,	the	following	crosses	were	performed:	
	
w;P[UAS‐dAda2bS2a];ada2ad189/TM6C		w;P[act‐Gal4];ada2ad189/TM6C	
or	
w;P[UAS‐dAda2bS2a];ada2bd842/TM6C		w;P[act‐Gal4];ada2bd842/TM6C	
	
The	 same	 crosses	 were	 applied	 to	 all	 the	 transgenic	 lines	 in	 the	 rescue	
experiments.	The	genotypes	analysed	are	presented	in	Table	3.2.		
3.5.4 Rescue	experiments		
To	 determine	 the	 rescuing	 abilities	 of	 the	 hybrid	 transgenes	 in	ada2ad189	 or	
ada2bd842	 mutant	 background,	 L3	 animals	 identified	 as	 non‐Tubby	 were	 gently	
transferred	 to	 new	 vials,	 allowed	 to	 develop	 at	 25°C,	 analysed	 and	 scored	 for	
puparium	formation	or	eclosion	rate.	The	number	of	animals	analysed	is	detailed	in	
Table	3.2.	 The	 phenotypes	 of	 the	 progeny	were	 inspected	 and	 pictures	were	 taken	
under	a	Nikon	SMZ‐1000	stereo‐microscope.	
3.6 Quantitative	Reverse‐Transcriptase	PCR		
For	quantitative	determination	of	transcripts	of	specified	genes	total	RNA	were	
isolated	 from	 white	 pupae	 with	 RNeasy	 Plus	 Mini	 Kit	 (Qiagen)	 according	 to	 the	
manufacturer’s	instructions.	First‐strand	cDNA	was	synthesized	from	1	µg	RNA	using	
TaqMan	 Reverse	 Transcription	 Reagent	 (ABI).	 Quantitative	 Real‐Time	 PCR	 (qPCR)	
was	 performed	 in	 an	 ABI	 7500	 RT‐PCR	 system	 using	 Maxima®	 SYBR	 Green/ROX	
qPCR	Master	Mix	(Fermentas).	mRNA	levels	were	normalized	to	the	expression	level	
of	the	Rp49	housekeeping	gene	and	the	ΔΔCT	method	was	used	for	the	calculation	of	
the	 relative	 abundances	 (Winer	 et	 al.,	 1999).	 The	 sequences	 of	 the	 primers	 are	
described	in	Table	3.3	(Zsindely	et	al.,	2009;	Pankotai	et	al.,	2010).	
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Table	3.3	Oligonucleotides	used	for	qPCR	
Oligonucleotides	 Sequence	(5′‐3′)
Fst	3′	fw	
Fst	3′	rv	
ACTATCGATTCTTCAGCGGTCTA
GTTACTCGGAAACGCCAAAT	
Cnc	3′	fw	
Cnc	3′	rv	
TGGAATCAGTGAGCCAGGA
TGTATAGTCGCCGGAAAAGG	
Hus1‐like	3′	fw	
Hus1‐like	3′	rv	
GGCCTTCTTTGGAGCACTT
CCACATCCTGTCGTACATCG	
phm	fw	
phm	rv	
GGATTTCTTTCGGCGCGATGTG
TGCCTCAGTATCGAAAAGCCGT	
dib	fw	
dib	rv	
TGCCCTCAATCCCTATCTGGTC
ACAGGGTCTTCACACCCATCTC	
sad	fw	
sad	rv	
CCGCATTCAGCAGTCAGTGG
ACCTGCCGTGTACAAGGAGAG	
spo	fw	
spo	rv	
TATCTCTTGGGCACACTCGCTG
GCCGAGCTAAATTTCTCCGCTT	
Rp49	fw	
Rp49	rev	
TGTCCTTCCAGCTTCAAGATGACCATC	
CTTGGGCTTGCGCCATTTGTG	
3.7 Immunofluorescence	of	polytene	chromosomes	
Polytene	 chromosome	 spreads	 were	 generated	 from	 the	 salivary	 glands	 of	
wandering	L3	larvae	of	the	genotypes	indicated	(Table	3.2).	The	larvae	were	dissected	
in	 30	 µl	 of	 Sol.	 I,	 transferred	 for	 40	 s	 to	 30	 µl	 of	 Sol.	 II,	 fixed	 for	 40	 s.	 in	 3.7%	
formaldehyde	Sol.	III	followed	by	incubation	in	Sol.	IV	for	1	min	(the	composition	of	
the	 solutions	 are	detailed	 in	Table	3.4).	 The	 slides	 containing	 chromosome	 spreads	
were	 checked	 under	 a	 phase	 contrast	 microscope,	 immersed	 for	 a	 few	 seconds	 in	
liquid	 nitrogen	 and	 stored	 in	 PBST	 (1PBS	 with	 0.1%	 Tween	 20).	 Samples	 were	
blocked	 in	 PBST	 plus	 5%	 fetal	 calf	 serum	 for	 1	 hour	 at	 room	 temperature	 and	
incubated	 overnight	 at	 4°C	 in	 a	mixture	 of	 primary	 antibodies.	Next	 day	 the	 slides	
were	washed	 3	 times	 for	 5	min	 in	 PBST	 followed	 by	 incubation	with	 a	mixture	 of	
secondary	antibodies	for	1	h	at	25°C.	The	slides	were	washed	in	PBST	3	 for	5	min	
and	 incubated	with	DAPI	 in	PBST	 for	2	min	 at	 25°C.	 Following	 the	 last	 10	minutes	
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wash	 in	 PBST	 the	 slides	were	 covered	with	Fluoromount aqueous	 based	mounting	
medium	(Sigma)	and	analysed	under	an	epi‐fluorescent	compound	microscope.		
Specific	 polyclonal	 antibodies	 for	histone	H3	acetylated	at	 lysine	9	 (H3K9ac,	
ab4441),	H3K14ac,	H4K5ac,	H4K12ac	were	from	Abcam	or	UPSTATE	and	were	used	
at	1:200	or	1:300	dilution.	Mouse	anti‐Pol	II	 (7G5)	antibodies	were	kindly	provided	
by	 Dr.	 László	 Tora	 and	 raised	 against	 specific	 peptides	 as	 previously	 reported	
(Georgieva	et	al.,	2000).	Secondary	antibodies	Alexa‐Fluor‐488‐conjugated	goat	anti‐
mouse	 IgG	 (Invitrogen, A‐11001)	 and	 Alexa‐Fluor‐555‐conjugated	 goat	 anti‐rabbit	
IgG	(Invitrogen,	A‐21429)	were	used	at	1:500	dilutions.	
Table	3.4	Solutions	prepared	for	immunostaining	of	polytene	chromosomes	
Components		 Solution	I	(1000	µl)	
Solution	II	
(500	µl)	
Solution	III		
(500	µl)	
Solution	IV
(1000	µl)	
10%	NP40	 56	µl 100	µl ‐ ‐	
10x	PBS	 100	µl 50	µl ‐ ‐	
37%	
paraformaldehyde	 ‐	 50	µl	 50	µl	 ‐	
96%	acetic	acid	 ‐ ‐ 225	µl 450	µl
H2O	 844	µl 300	µl 225	µl 550	µl
	
37%	paraformaldehyde	
0.185	g	paraformaldehyde	(SIGMA)	
7	μl	1	M	NaOH	
Up	to	500	μl	distilled	H2O	
PBST	(200	ml)	
20	ml	10PBS	
200	µl	Tween20	
Blocking	solution	(1500	µl)	
15	µl	Tween	20	
150	µl	10PBS	
150	µl	FCS		
	
Stained	 samples	 were	 examined	 with	 an	 OLYMPUS	 BX51	 microscope	 and	
photos	were	taken	with	an	Olympus	DP70	camera	using	identical	settings	for	mutant	
and	control	samples. 
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 	Chapter 4.
Results		
4.1 Engineering	the	chimeric	transgenes		
Previous	 studies	 in	 D.	melanogaster	 have	 reported	 the	 important	 role	 of	 the	
dSAGA	 and	 dATAC	 HAT	 complexes	 in	 modulating	 the	 chromatin	 structure	 by	
targeting	specific	lysine	residues	on	histone	H3	and	H4	for	acetylation	(Pankotai	et	al.,	
2005;	Ciurciu	et	al.,	2006).	GCN5	represents	the	catalytic	subunit	of	SAGA	and	ATAC	
complexes,	and	together	with	ADA‐type	adaptor	proteins	modulates	the	activity	and	
specificity	 of	 the	 HAT	 complexes	 (Wu	 et	 al.,	 2004;	 Nagy	 and	 Tora,	 2007).	
Immunostaining	 of	 polytene	 chromosomes	 of	ada2bd842	 null	mutants	 indicated	 that	
the	levels	of	histone	H3K9	and	K14	acetylation	were	severely	decreased	(Pankotai	et	
al.,	 2005;	 Ciurciu	 et	 al.,	 2006).	 Independently	 obtained	 results	 corroborated	 these	
data	and	complex	purification	studies	revealed	that	dADA2b	was	indeed	a	subunit	of	
the	 SAGA‐type	 Drosophila	 complex	 (Kusch	 et	 al.,	 2003).	 Similar	 experimental	
approaches	 demonstrated	 that,	 in	 contrast	 to	 the	 above	 described	 findings,	 the	
ada2ad189	 null	mutation	 causes	 a	 decrease	 in	 the	 level	 of	 histone	 H4	 acetylated	 on	
K5	and	K12	 (Ciurciu	 et	 al.,	 2006),	 and	 dADA2a	was	 identified	 as	 a	 component	 of	 a	
smaller	complex	designated	as	dATAC	(Guelman	et	al.,	2006).	Subsequently,	detailed	
analysis	 of	 the	 dATAC	 complex	 revealed,	 in	 addition	 to	 dGCN5,	 the	 presence	 of	
another	 HAT	 catalytic	 subunit,	 dATAC2	 (KAT14)	 with	 a	 pivotal	 role	 in	 H4K16	
acetylation	in	embryos	(Suganuma	et	al.,	2008).		
All	 the	 above	 observations	 led	 us	 to	 question	 whether	 the	 histone	 H4	
acetyltransferase	activity	of	dATAC	can	be	attributed	to	dGCN5	or	to	another	HAT	of	
the	complex.	To	find	an	answer	to	this	question	the	effect	of	gcn5E333st	mutation	was	
tested	on	the	acetylation	of	histones	in	L3	stage	larvae.	We	performed	western	blot	of	
protein	extract	of	wild	type	(w1118)	and	gcn5E333st	 late‐third‐instar	 larvae.	As	 loading	
control	 the	same	membrane	was	blotted	with	H3	antibody.	We	observed	that	when	
the	function	of	the	dGCN5	catalytic	subunit	is	altered	a	significantly	reduced	level	of	
histone	H3K14	and	H4K12	acetylation	is	observed	(Fig.	4.1).	In	light	of	the	above	and	
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earlier	 findings	 regarding	 the	 changes	 of	 acetylated	 histone	 levels	 in	 ada2	 null	
mutants,	we	wondered	on	the	possible	roles	of	dADA2	factors	 in	dATAC	and	dSAGA	
complexes.	
 
Fig.	4.1	Loss	of	function	of	dGCN5	protein	influences	the	acetylation	level	of	H4K12	and	H3K14.	
Immunoblots	 of	 total	 protein	 extracts	 of	 wild‐type	 and	 dGcn5E333st	 late	 third‐instar	 larvae	
developed	with	antibodies	specifically	recognizing	H4K12ac	and	H3K14ac.	
The	 high	 degree	 of	 sequence	 similarity	 between	 the	 two	 dADA2	proteins	 and	
the	 fact	 that	 they	 are	 specifically	 recruited	 to	 one	 or	 the	 other	 HAT	 complexes	
suggests	the	presence	of	a	sequence	unique	for	both	dADA2	proteins	that	is	essential	
for	 specific	 association	 to	 either	 dSAGA	 or	 dATAC	 complex.	 Both	 dADA2	 proteins	
contain	 a	 Zinc	 finger	 domain	 and	 SANT	 domain	 within	 their	 highly	 conserved	 N‐
terminal	 region	 (>50%)	 (Kusch	 et	 al.,	 2003;	Muratoglu	 et	 al.,	 2003).	 The	 homology	
between	dADA2a	and	dADA2b	at	 the	C‐terminus	 is	much	 less	pronounced	(30‐50%	
homology)	 (Kusch	 et	 al.,	 2003)	 where	 only	 dADA2a	 accommodates	 a	 SWIRM	
(Swi/RSC8/Moira)	domain.	Thus,	we	can	hypothesize	that	their	different	recruitment	
to	 dSAGA	 or	 dATAC	 complexes	 can	 be	 attributed	 to	 the	 origin	 of	 the	 C‐terminal	
region.		
In	order	to	gain	more	information	regarding	the	hypothesis	that	the	two	dADA2	
factors	 might	 play	 roles	 in	 modulating	 dGCN5	 specificity	 in	 dATAC	 or	 dSAGA	
complexes,	we	constructed	recombinant	chimeric	dADA2’s	where	different	regions	of	
dADA2b	protein	was	switched	with	domains	of	dADA2a	protein.	We	believe	that	due	
to	 the	sequence	homology	between	dADA2	proteins	 the	obtained	chimeric	proteins	
will	maintain	similar	conformation	to	the	wild‐type	proteins.		
By	joining	PCR‐generated	DNA	fragments	corresponding	to	individual	domains	
of	dADA2a	(light	grey	boxes	–	Fig.	4.2)	and	dADA2b	(dark	grey	boxes	–	Fig.	4.2)	we	
constructed	four	chimeric	proteins	(Fig.	4.2).	A	detailed	description	of	their	cloning	is	
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presented	in	Chapter	3‐Materials	and	methods.	The	four	recombinant	chimeras	are	as	
follows:		
 dADA2bS2a	encodes	amino	acids	1‐145	of	dADA2b	fused	to	amino	acids	
231‐542	of	dADA2a;		
 dADA2bM2a	 encodes	 amino	 acids	 1‐181	 of	 dADA2b	 fused	 to	 amino	
acids	231‐542	of	dADA2a;		
 dADA2bL2a	encodes	amino	acids	1‐233	of	dADA2b	fused	to	amino	acids	
231‐542	of	dADA2a;		
 dADA2a2b	encodes	amino	acids	1‐301	of	dADA2a	fused	to	amino	acids	
118‐418	of	dADA2b.	Full	length	dAda2a	and	dAda2b	genes	were	included	as	controls	
(Fig.	4.2).	Restriction	enzyme	digestion	and	DNA	sequencing	confirmed	the	identity	of	
each	chimeric	construct	and	controls.	
 
Fig.	 4.2	 Domain	 structure	 of	 dADA2a,	 dADA2b	 proteins	 and	 overview	 of	 dADA2a/dADA2b	
chimeras.	 Numbers	 above	 and	 below	 the	 boxes	 indicate	 the	 relative	 amino	 acid	 sequence	
position	 within	 each	 protein.	 The	 vertical	 white	 bars	 indicate	 the	 positions	 where	 the	 two	
dADA2	proteins	were	assembled	to	generate	chimeras.	
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The	chimeric	constructs	were	first	tested	for	their	expression	in	Drosophila	S2	
cell	line	to	confirm	that	improper	folding	of	the	chimeric	proteins	did	not	cause	rapid	
degradation.	Thus,	the	plasmids	expressing	FLAG	epitope	tagged	chimeric	constructs	
were	transiently	transfected	into	Drosophila	S2	cells	and	verified	by	western	blot	that	
each	 plasmid	 directed	 the	 expression	 of	 a	 chimeric	 protein	with	 the	 expected	 size. 
Immunoblotting	with	anti‐FLAG	antibody	exhibits	 the	 same	 levels	of	 expression	 for	
the	 wild‐type	 proteins	 and	 chimeras.	 The	 same	 membrane	 was	 blotted	 with	 anti‐
Tubulin	antibody	as	loading	control	(Fig.	4.3).	
 
Fig.	4.3	Transient	expression	of	chimeric	constructs	 in	Drosophila	S2	cell	 line.	Cell	 lysate	was	
prepared	24h	following	transfection	and	immunoblotted	using	FLAG	antibody.	
The	in	vivo	characterization	of	the	function	of	the	chimeric	proteins	was	carried	
out	by	generating	Drosophila	transgenic	lines	aiming	to	assess	the	ability	of	chimeric	
genes	 to	complement	 the	 loss	of	dADA2a	and	dADA2b	 functions.	For	 the	 transgenic	
constructs	we	used	coding	regions	of	dAda2	genes	without	any	epitope	 tag	to	avoid	
possible	interference	with	their	function	or	the	occurrence	of	unwanted	interactions.	
We	inserted	the	coding	regions	of	the	chimeric	proteins	into	a	transformation	vector	
allowing	site	specific	insertion	into	the	Drosophila	genome.	This	approach	was	chosen	
since	 although	 the	 classical	 method	 of	 P‐element	 mediated	transformation	is	 quite	
efficient	the	transgenes	can	land	almost	anywhere	in	the	genome,	even	in	an	essential	
gene.	Moreover,	 depending	 on	where	 the	P‐element	 lands,	 in	 some	 cases,	 it	 can	 be	
under	 the	 influence	of	nearby	enhancers	or	 silencers,	which	 can	and	might	 affect	 a	
transgene's	expression.	Considering	these	factors	and	to	bypass	the	randomness	of	P‐
element	 transformation	which	 can	 directly	 influence	 the	 comparisons	 between	 the	
activities	 of	 two	 or	 more	 constructs,	 we	 generated	 transgenic	 lines	 using	 ɸC31	
integrase	system	(Groth	et	al.,	2004).		
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The	 ɸC31	 integrase	 is	 a	 sequence‐specific	 recombinase	 encoded	 within	 the	
genome	of	the	bacteriophage	and	can	mediate	recombination	between	two	sequences	
termed	 attachment	 sites	 (att),	 one	 found	 in	 the	 phage	 (attP)	 and	 the	 other	 in	 the	
bacterial	host	(attB)	(Groth	et	al.,	2004).	ɸC31	integrase	can	unidirectional	integrate	
the	 transgene	 of	 interest	 into	 a	 target	 genome	 and	 requires	 no	 cofactors.	 The	
integrated	 transgenes	 are	 stably	 expressed	 and	 heritable.	 Since	 all	 constructs	 are	
integrated	 into	 the	 same	 locus	within	 the	genome	 the	expression	of	 the	 transgenes	
can	be	directly	compared.	By	performing	embryos	injection	with	plasmids	containing	
coding	regions	of	 the	chimeras	we	generated	 transgenic	 lines	and	 following	genetic	
crosses	carrier	stocks	were	established.	As	control	we	generated	transgenic	lines	with	
full‐length	coding	regions	of	dAda2a	and	dAda2b	(short	isoform)	genes.	Subsequently,	
we	 tested	 the	 chimeric	 transgenes	 for	 their	 ability	 to	 rescue	 the	 ada2ad189	 or	
ada2bd842	null	mutations.		
4.2 Expression	of	dADA2	chimeras	partially	rescues	the	ada2ad189	or	
ada2bd842	mutants	
Functional	 characterization	 of	 dAda2b	 gene	 in	 D.	 melanogaster	 has	 been	
previously	 reported	 (Qi	 et	 al.,	 2004;	 Pankotai	 et	 al.,	 2005).	 ada2bd842	 null	 mutants	
were	 generated	by	 remobilizing	P	 element	 localized	 close	 to	 the	5’	 ends	 of	dAda2b	
gene	and	the	biological	consequences	of	this	mutation	was	examined	(Pankotai	et	al.,	
2005).	The	animals	homozygous	for	the	ada2bd842	null	mutation	have	been	described	
as	pupal	(P5	stage)	 lethal	of	which	only	a	small	percentage	could	reach	the	pharate	
adult	 (pA)	 stage	 (Pankotai	 et	 al.,	 2005).	 To	 learn	 more	 about	 the	 functional	
importance	 of	 dADA2b	 protein	 in	 D.	 melanogaster	 we	 generated	 transgenic	 lines	
expressing	 dADA2a/dADA2b	 chimeric	 proteins	 in	 ada2bd842	 null	 animals	 and	
observed	whether	any	phenotypical	changes	will	occur.	
The	 rescue	 experiments	 performed	 for	 the	 expression	 of	 the	 pUAS‐dAda2b	
transgene	as	 control	under	 the	 regulation	of	 the	Actin‐Gal4	driver	partially	 rescues	
the	P5	lethality	phenotype	of	ada2bd842	null	mutants	and	supports	the	development	of	
80%	of	the	animals	to	pupal	stage	14	(P14).	The	phenotypic	features	characteristic	of	
the	P5	and	P14	stages	(in	the	latter	adult	head,	wings	and	legs	are	well	differentiated	
and	 clearly	 visible,	 mature	 bristles	 are	 recognizable)	 made	 the	 scoring	 unbiased	
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(Fig.	4.4).	 Although	 the	 P14	 stage	 animals	 are	 almost	 completely	 developed,	 they	
never	 emerge	 as	 adults.	 A	 full	 rescue	with	 this	 transgene	 is	 not	 expected	 since	 the	
dAda2b	 cDNA	 that	was	used	 to	generate	 the	pUAS‐dAda2b	 transgenic	 lines	encodes	
only	the	short	isoform	of	dADA2b	thus	explaining	lack	of	full	rescue.	Recent	studies	in	
our	 group	have	 also	 indicated	 that	 the	 short	 isoform	of	 dADA2b	 alone	 is	 unable	 to	
complement	 the	ada2bd842	null	mutation	 (Pankotai	et	al.,	2013b).	The	pUAS‐dAda2a	
transgene	expression	in	ada2bd842	mutant	background	resulted	in	50%	of	the	animals	
reaching	P12	pharate	adult	stage	(Fig.	4.4)	with	phenotype	characteristics	similar	to	
those	of	escaper	ada2bd842	mutants:	 the	size	of	 the	head	was	 reduced	and	 the	body	
dried	out.		
 
Fig.	4.4	The	dAda2a2b	chimeric	 transgene	partially	 rescues	 the	phenotypic	characteristics	of	
ada2bd842	mutation.	The	percentages	of	animals	that	reach	in	the	indicated	developmental	stage	
are	shown.	Each	column	represents	specific	developmental	stages.	The	fifth	stage	pupal	lethality	
(P5)	 associated	 with	 ada2bd842	 null	 mutation	 is	 rescued	 to	 pharate	 adult	 stage	 by	
overexpression	 of	 pUAS‐dAda2a2b	 chimeric	 transgene.	 A	 small	 percentage	 of	 transgenic	
animals	complete	the	pharate	adult	stage	and	hatch	(indicated	by	star).	
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Out	of	the	four	of	dADA2	chimeras	tested	in	ada2bd842	mutant	background,	only	
the	 expression	 of	 chimeric	 transgene	where	 N‐terminal	 of	 dAda2a	 was	 fused	 to	 C‐
terminal	 of	 dAda2b	 resulted	 in	 partial	 but	 significant	 rescue	 of	 the	 null	 mutants	
phenotype	(Fig.	4.4).		
Notably,	 under	 the	 control	 of	Actin‐GAL4	driver	more	 than	50%	of	 the	pUAS‐
dAda2a2b	transgene‐carrier	animals	could	complete	stage	P5	and	developed	as	far	as	
P14	stage	when	an	adult	head,	wings	and	 legs	are	differentiated	and	clearly	visible	
(Fig.	4.4).	However,	a	two	days	delay	was	observed	in	their	development	as	compared	
to	 pUAS‐dAda2a2b	 transgene‐carries	 ada2bd842	 heterozygous	 siblings.	 Moreover,	 a	
small	percentage	of	the	ada2bd842	null	mutant	animals	expressing	the	pUAS‐dAda2a2b	
transgene	 could	 emerged	 as	 adults,	 although	 they	 died	within	 12	 hours	with	 their	
wings	still	folded	(Fig.	4.5‐Hatched).		
 
Fig.	4.5	The	dAda2a2b	chimeric	 transgene	partially	 rescues	 the	phenotypic	characteristics	of	
ada2bd842	mutation.	 Images	 of	 ada2bd842,	 wild	 type	 (w1118)	 and	 ada2bd842	 containing	 pUAS‐
dAda2a2b	transgene	at	pupal	stages	(P)	indicated	on	each	separate	picture.	Compared	to	wild	
type,	 ada2bd842	 mutants	 expressing	 dAda2a2b	 chimeric	 transgene	 exhibit	 a	 normal	 body	
development.	
The	 ada2bd842	 animals	 expressing	 the	 dADA2bS2a	 and	 dADA2bL2a	 chimeric	
transgenes,	 where	 different	 lengths	 of	 dADA2b	 N‐terminal	 was	 fused	 to	 the	 C‐
terminal	 half	 of	 dADA2a,	 reached	 P12	 stage	 at	 a	 slightly	 higher	 percentage	 than	
compared	with	the	null	mutants.	Although	the	data	might	suggest	a	partial	rescue,	we	
consider	 the	 results	 not	 significant	 since	 both	 dADA2b/2a	 transgene‐carries	
ada2bd842	 mutants	 had	 the	 same	 phenotypical	 characteristics	 as	 the	 null	 mutant	
animals.	 Moreover,	 the	 data	 obtained	 from	 dAda2bS2a	 and	 dAda2bL2a	 transgene	
carriers	ada2bd842	mutants	are	less	significant	when	compared	with	the	results	of	the	
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rescue	 experiments	 for	 the	 ada2bd842	 mutant	 animals	 expressing	 the	 dAda2a2b	
chimeric	transgene.		
The	 combined	 results	 of	 the	 rescue	 experiments	 have	 shown	 that	 chimeric	
protein	 dADA2a2b,	 where	 the	 N‐terminal	 of	 dADA2a	 is	 fused	 to	 the	 C‐terminal	 of	
dADA2b,	 can	 partially	 substitute	 the	 function	 of	 dADA2b	 protein	 in	 ada2bd842	 null	
mutant	animals.		
The	chimeric	transgenes	were	next	investigated	for	their	potential	to	rescue	the	
characteristic	 features	 of	 the	 ada2ad189	 mutation.	 The	 ada2ad189	 is	 a	 null	 allele	
mutation	and	homozygotes	can	survive	for	up	to	2	weeks	in	L3	larval	stage	but	fail	to	
undergo	prepupal	contraction	or	form	malformed	brownish	pupae	with	incompletely	
everted	anterior	spiracles	(Ciurciu	et	al.,	2006).	In	our	rescue	experiments	Actin‐Gal4	
driven	expression	of	the	pUAS‐dAda2a	 transgene	resulted	 in	complete	rescue,	while	
the	pUAS‐dAda2b	transgene	had	no	effect	on	the	phenotype	(Fig.	4.6).		
 
Fig.	4.6	The	 L3	 lethal	 phenotype	 of	 ada2ad189	mutation	 is	 rescued	 by	 expression	 of	 chimeric	
transgenes.	 The	 graphic	 depicts	 the	 quantification	 of	 the	 rescue	 experiments.	 Each	 column	
represents	specific	developmental	stage.	Animals	expressing	either	of	the	two	chimeras	reached	
pharate	adult	stage	P12	(indicated	by	star).	
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Very	similar	results	we	could	observe	for	ada2ad189	mutant	animals	that	express	
dADA2bM2a	 chimeric	 transgene.	 Out	 of	 241	 larvae	 expressing	 the	 transgene	
containing	a	medium	fragment	(1‐181	aa)	of	dAda2b	N‐terminal	region	fused	to	the	
dAda2a	 C‐terminal	 region,	226	 larvae	 formed	normal	brownish	P1	prepupae	out	of	
which	 86	 reached	 pupa	 stage	 (P5).	 Four	 animals	 out	 of	 86	 P5	 stage	 pupae	 could	
develop	 further	 to	 pharate	 adult	 (P12)	 stage	 (Fig.	4.6).	 Compared	 to	ada2ad189	 null	
animals,	 the	homozygous	mutants	 expressing	 either	dADA2bS2a	or	dADA2bM2a	 are	
more	similar	to	wild	type	animals	in	shape,	colour	and	texture	(Fig.	4.7).		
 
Fig.	4.7	The	 L3	 lethal	 phenotype	 of	 ada2ad189	mutation	 is	 rescued	 by	 expression	 of	 chimeric	
transgenes.	 Loss	 of	 dADA2a	 function	 results	 in	 malformed	 pupae‐like	 structures	 while	 the	
expression	 of	 dAda2bS2a	 or	 dAda2bM2a	 transgene	 partly	 rescues	 the	 mutant	 phenotype.	
Compared	 to	wild	 type	 the	 transgenic	 animals	 present	 the	 same	 features	 characteristic	 for	
pharate	adult	P12	stage	when	the	abdominal	bristle	becomes	visible	and	wings	darken	to	black.	
In	 contrast	 to	 the	 ada2ad189	 mutants	 that	 showed	 arrested	 development	 and	
persisted	 in	 the	L3	 larval	 stage	 for	up	to	2	weeks,	 the	expression	of	dAda2bS2a	 and	
dAda2bM2a	 transgenes	 helped	 to	 rescue	 this	 developmental	 defect	 and	 the	 animals	
reached	the	P5	stage	in	4	days.	However,	a	two	days	delay	in	their	development	was	
recorded	compared	to	 that	of	wild	type.	 Interestingly,	 the	expression	of	dADA2bL2a	
chimeric	protein,	where	1‐233	amino	acids	of	dADA2b	N‐terminus	are	fused	in	front	
of	 the	dADA2a	C‐terminal	region	(231‐542	amino	acids),	was	not	able	to	rescue	the	
loss	of	dADA2a	function	(Fig.	4.6).	A	possible	explanation	for	the	failure	of	dADA2bL2a	
chimeric	 transgene	 to	 show	 any	 phenotypical	 rescue	 for	 ada2ad189	mutant	 animals	
might	be	 connected	 to	 its	 conformation.	The	 chimeric	ADA2bL2a	construct	 includes	
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not	 only	 the	 highly	 conserved	N‐terminal	 region	 but	more	 than	 half	 of	 the	dAda2b	
gene	 which	 comprises	 non‐conserved	 regions	 as	 well.	 It	 is	 possible	 that	 the	
dADA2bL2a	chimeric	protein	is	improperly	folded	and	it	is	subjected	to	proteasomal	
degradation.	 Other	 possibility	 might	 be	 that	 the	 conformation	 of	 the	 dADA2bL2a	
chimeric	protein	interferes	with	its	proper	function	as	substitute	of	dADA2a	protein.	
As	 a	 result	 no	 significant	 effect	 can	 be	 observed	 on	 the	 rescue	 experiments	 for	
ada2ad189	 null	mutant	 animals	 which	 express	 the	 dADA2bL2a	 chimeric	 transgene.	
Likewise,	the	pUAS‐dAda2a2b	transgene	expression	in	ada2ad189	mutant	background	
presented	 no	 significant	 rescue	 of	 phenotype	 relative	 to	 pUAS‐dAda2a	 transgene	
(Fig.	4.6).		
Taken	 together,	 the	 rescue	 experiments	 suggest	 that	 the	 C‐terminal	 region	 of	
both	proteins,	dADA2a	and	dADA2b,	has	an	essential	role	in	determining	the	rescue	
ability	 of	 the	 chimeric	 transgenes	 in	 ada2ad189	 and	 ada2bd842	 mutant	 animals,	
respectively.	The	high	homology	between	 the	N‐terminal	 regions	of	 the	 two	dADA2	
proteins	 is	 seemingly	 sufficient	 to	 maintain	 the	 proper	 folding	 of	 the	 chimeric	
proteins,	 while	 the	 C‐terminal	 region	might	 determine	 their	 incorporation	 into	 the	
dSAGA	or	dATAC	complexes	partially	restoring	one	or	the	other	dADA2	functions.	
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4.3 	The	 acetylation	 level	 of	 histones	 H3	 or	 H4	 at	 specific	 lysine	
residues	 is	 restored	 in	 ada2	 null	mutants	 by	 the	 expression	 of	
dADA2	chimeric	proteins	
It	 is	well	 established	 that	 GCN5	 represents	 the	 catalytic	 subunit	 of	 SAGA	 and	
ATAC	 histone	 acetyltransferase	 complexes,	 although	 other	 ATAC	 subunits	 with	
catalytic	activity	have	also	been	suggested	(Grant	et	al.,	1997;	Guelman	et	al.,	2006;	
Suganuma	 et	 al.,	 2008).	 Recent	 studies	 demonstrated	 that	 gcn5E333st	 and	 ada2ad189	
mutants	 display	 similar	 phenotypes	 in	 respect	 of	 both	 developmental	 failure	 and	
reduced	acetylation	on	histone	H4	at	lysine	5	and	12	(Ciurciu	et	al.,	2006).	Moreover,	
mutation	of	the	dADA2b	protein	reduces	the	level	of	acetylated	H3	at	lysine	9	and	14	
as	 determined	 by	 polytene	 chromosome	 stainings	 (Qi	 et	 al.,	 2004;	 Pankotai	 et	 al.,	
2005;	 Ciurciu	 et	 al.,	 2006).	 In	 agreement	with	 previous	data	we	 consistently	 found	
that	 gcn5E333st	 null	 mutation	 affected	 the	 levels	 of	 histone	 H3	 and	 H4	 acetylation.	
Overall,	 these	 observations	 suggest	 that	 the	 presence	 of	 the	 dADA2a	 or	 dADA2b	
adaptor	protein	in	a	complex	correlates	with	the	histone	specificity	of	that	complex.	
To	further	support	the	role	of	dADA2	protein	in	histone	acetylation	and	to	emphasize	
the	 results	 of	 the	 rescue	 experiments	 we	 performed	 immunostaining	 of	 polytene	
chromosomes.	We	analysed	whether	 the	pUAS‐dAda2bS2a,	 pUAS‐dAda2bM2a,	 pUAS‐
dAda2bL2a	 or	 pUAS‐dAda2a2b	 transgenes	 are	 able	 to	 restore	 the	 decreased	
acetylation	characteristic	for	ada2ad189	or	ada2bd842	null	mutation.		
Polythene	 chromosome	 staining	 of	 ada2bd842	 mutant	 L3	 larvae	 that	 express	
pUAS‐dAda2a2b	chimeric	transgene	were	prepared	to	analyse	the	chimera’s	effect	on	
histone	H3	 acetylation	 on	 lysine	 9	 and	 14.	 Chromosomes	 of	 the	ada2bd842	 mutants	
which	 express	 dADA2a2b	 chimeric	 protein	 where	 the	 N‐terminal	 domain	 of	 the	
dADA2b	protein	had	been	replaced	with	the	N‐terminal	301	aa	of	dADA2a	revealed	
increased	 acetylation	on	histone	H3	 at	 the	 lysines	 indicated	when	 compared	 to	 the	
ada2bd842	null	mutants	(Fig.	4.8).	 In	contrast,	the	pUAS‐dAda2bS2a,	pUAS‐dAda2bM2a	
or	pUAS‐dAda2bL2a	chimeric	 transgenes	had	no	detectable	effect	on	either	H3K9	or	
H3K14	acetylation	being	in	agreement	with	their	failure	in	rescue.		
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Fig.	4.8	The	effect	of	dAda2a2b	chimeric	 transgene	 in	ada2bd842	mutant	on	H3K9	and	H3K14	
acetylation.	 Chromosomes	 immunostained	 with	 polyclonal	 antibodies	 specific	 for	 individual	
acetylated	 lysine	 residues	 of	 H3	 (red),	 as	 indicated	 on	 the	 left,	 and	 with	 a	 Pol	 II‐specific	
monoclonal	 antibody	 (Pol	 II	7G5,	 green)	 are	 shown.	Genotypes	 are	 indicated	 at	 the	 top.	The	
images	of	the	immunostaining	in	different	mutants	were	obtained	with	identical	data‐recording	
settings.	
To	 validate	 our	 polytene	 chromosome	 staining	we	 performed	western	 blot	 of	
protein	 extracts	 from	 wild‐type,	 ada2bd842	 null	 mutants	 and	 ada2bd842	 mutants	
expressing	 pUAS‐dAda2a2b	 chimeric	 transgene.	 The	 immunoblots	 were	 developed	
with	specific	antibodies	and	we	could	observe	significant	 increase	in	the	acetylation	
levels	for	histone	H3	at	lysine	9	and	14	in	ada2bd842	mutant	animals	expressing	pUAS‐
dAda2a2b	chimeric	transgene	compared	to	ada2bd842	null	animals	(Fig.	4.9).	
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Fig.	4.9	The	effect	of	dAda2a2b	chimeric	 transgene	 in	ada2bd842	mutant	on	H3K9	and	H3K14	
acetylation.	Western	blot	of	protein	extracts	of	wild‐type,	ada2bd842	and	pUAS‐dAda2a2b/act‐
Gal4;	 ada2bd842	 L3	 larvae	 developed	with	 antibodies	 as	 indicated	 on	 the	 left.	The	 blots	were	
stripped	and	developed	with	H3‐specific	antibody	to	demonstrate	equal	loading.	
Previous	 immunostainings	of	polytene	chromosomes	have	shown	that	the	 loss	
of	 dADA2a	 activity	 results	 in	 a	 dramatic	 decrease	 in	 the	 levels	 of	 H4K5ac	 and	
H4K12ac	(Ciurciu	et	al.,	2006).	Our	rescue	experiments	have	demonstrated	 that	 the	
expression	 of	 dADA2bS2a	 or	 dADA2bM2a	 chimeric	 transgenes	 can	 partially	 restore	
the	 function	of	dADA2a	protein	 in	ada2ad189	mutant	 animals.	We	 therefore	 found	 it	
interesting	 to	 determine	 whether	 these	 chimeric	 proteins	 can	 also	 restore	 the	
decreased	 histone	 acetylation	 pattern	 specific	 for	ada2ad189	 null	mutation.	 For	 this,	
we	 studied	 the	 acetylation	 levels	 of	 H4K5	 and	 K12	 in	ada2ad189	mutant	 animals	 in	
which	 dADA2a	 function	 was	 provided	 by	 the	 chimeric	 transgenes.	 Polytene	
chromosome	 staining	 of	 transgene	 carrier	 late‐third‐instar	 larvae	 with	 antibodies	
specific	for	acetylated	H4K5	or	H4K12	revealed	that	the	two	chimeric	transgenes	that	
contain	the	C‐terminal	region	of	dAda2a	merged	with	N‐terminal	of	dAda2b	displayed	
similar	staining	intensity	to	wild	type	animals	(Fig.	4.10).	This	might	suggest	that,	in	
accord	 with	 the	 result	 of	 the	 rescue	 experiments,	 the	 pUAS‐dAda2bS2a	 or	 pUAS‐
dAda2bM2a	 chimeric	 transgenes	 can	 partially	 substitute	 for	 the	 loss	 of	 dADA2a	
function	 and	 might	 produce	 acetylation	 competent	 HAT	 complexes	 in	 ada2ad189	
mutant	animals.		
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Fig.	4.10	Immunostaining	of	polytene	chromosomes	obtained	 from	w1118,	ada2ad189	and	pUAS‐
dAda2bS2a,	pUAS‐dAda2bM2a	chimeric	transgenes	in	ada2ad189	mutant	background.	Antibodies	
specific	for	histone	H4K5ac,	H4K12ac	(red)	and	Pol	II	7G5	(green)	were	used	as	indicated	on	the	
left.	Genotypes	are	indicated	at	the	top.		
The	 immunoblotting	 of	 total	 protein	 extract	 from	ada2ad189	 larvae	 expressing	
pUAS‐dAda2bS2a	 or	 pUAS‐dAda2bM2a	 transgenes	 also	 indicated	 a	 restored	 level	 of	
H4K5	and	K12	acetylation	similar	to	wild	type	(Fig.	4.11).		
 
Fig.	4.11	Western	blots	of	protein	extracts	of	w1118,	ada2ad189	and	ada2ad189	mutants	expressing	
pUAS‐dAda2bS2a	 or	 pUAS‐dAda2bM2a	 chimeric	 transgenes.	 The	membranes	 were	 developed	
with	the	antibodies	indicated	on	the	left.	The	blots	were	stripped	and	developed	with	H3‐specific	
antibody	to	demonstrate	equal	loading.	
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In	 addition	 to	 the	 decrease	 acetylation	 for	 H4K5	 and	 K12,	 the	 ada2ad189	 null	
mutation	has	significant	effect	on	the	structure	of	the	polythene	chromosomes.	They	
appear	 as	 fragile	 and	 display	 a	 distorted	 banding	 pattern	 (Pankotai	 et	 al.,	 2005;	
Ciurciu	 et	 al.,	 2006).	 It	 is	 not	 clear	 whether	 these	 structural	 characteristics	 of	 the	
polythene	 chromosomes	 are	 as	 a	 result	 of	 loss	 of	dAda2a	 function	 or	 represents	 a	
more	 general	 effect	 due	 to	 the	 delayed	 development	 of	 these	 animals.	 In	 our	
experiments	 the	 ectopic	 expression	 of	 chimeric	 pUAS‐dAda2bS2a	 and	 pUAS‐
dAda2bM2a	 transgenes	 in	 ada2ad189	 mutant	 background	 substantially	 improved	 the	
distorted	banding	pattern	of	polytene	chromosomes	(Fig.	4.12).		
 
Fig.	4.12	Phase‐contrast	 images	of	polytene	chromosomes	prepared	 from	wild	 type,	ada2ad189	
and	 pUAS‐dAda2bS2a	 or	 pUAS‐dAda2bM2a	 transgene‐carriers	 ada2ad189	mutant	 animals.	The	
abnormal	morphology	of	ada2ad189	polytene	chromosomes	 is	rescued	by	pUAS‐dAda2bS2a	and	
pUAS‐dAda2bM2a	transgenes.	
The	 ectopic	 expression	 of	 Actin‐Gal4‐driven	 pUAS‐dAda2bL2a	 or	 pUAS‐
dAda2a2b	 chimeric	 transgenes	 in	 dATAC	 mutants	 had	 no	 significant	 effect	 on	 the	
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level	of	histone	H4	acetylation	at	K5	or	K12	being	in	agreement	with	the	results	of	the	
rescue	experiments.	
According	 to	 the	polytene	chromosome	 immunostaining,	we	can	hypothesized	
that	 the	 in	 vivo	 changes	 of	 the	 acetylation	 levels	 observed	 for	 histone	 H3	 and	 H4	
lysines	 in	 ada2ad189	 or	 ada2bd842	 mutants	 expressing	 chimeric	 transgenes,	 are	
influenced	by	 the	C‐terminal	 regions	of	dADA2a	or	dADA2b	proteins.	 These	 results	
might	 suggest	 that	 functionally	 distinct	 HAT	 complexes	 can	 be	 generated	 which	
contain	as	subunits	the	chimeric	dADA2	proteins.	These	observations	further	validate	
our	results	of	the	rescue	experiments.	
4.4 Chimeric	 dADA2	 proteins	 did	 not	 improve	 the	 expression	 of	
selected	genes	affected	by	ada2ad189	or	ada2bd842	mutation	
Recently	 it	 has	 been	 reported	 that	 the	 expression	 of	 a	 small	 set	 of	 genes	 are	
influenced	by	 the	ada2bd842	null	mutation,	whereas	a	considerable	number	of	genes	
are	affected	by	 the	 loss	of	 function	of	dATAC‐specific	 subunit	(Zsindely	et	al.,	2009;	
Pankotai	 et	 al.,	 2010).	 Based	 on	 the	 results	 of	 the	 rescue	 experiments	 and	 the	
polytene	chromosomes	 immunostainings	we	can	hypothesize	 that	 the	expression	of	
the	chimeric	 transgenes	 in	ada2	mutants	might	determine	gene	expression	changes	
as	well.	To	study	the	molecular	consequences	of	the	chimeric	transgene	expression	in	
ada2	mutants	we	 compared	 the	mRNA	 levels	 of	 selected	 genes	 from	wild	 type	 and	
chimeric	 transgene	expressers	by	Quantitative	Real‐Time	PCR.	mRNA	samples	were	
obtained	 from	 synchronized	white	 pupae	 as	 described	 in	Chapter	3	 –	Material	and	
Methods.	
From	the	genes	affected	by	the	ada2bd842	mutation	we	selected	to	analyse	those	
which	were	found	to	be	either	down‐regulated,	such	as	Sug	(Sugarbabe)	and	Cnc	(Cap	
‘n’	collar),	or	up‐regulated,	such	as	Fst	 (Frost)	and	Hus	1‐like	 (Zsindely	et	al.,	2009).	
Sugarbabe	gene	 encodes	 a	 predicted	 zinc	 finger	 protein	 that	 regulates	 insulin	 gene	
expression	 in	 the	 Drosophila	 neurosecretory	 cells.	 Sug	 gene	 is	 highly	 induced	 in	
sugar‐fed	larvae	in	the	fat	body	and	parts	of	the	midgut	(Zinke	et	al.,	2002). Cnc	gene	
affects	cell	proliferation	and	development	(Deng	and	Kerppola,	2013)	while	Hus	1‐like	
gene	is	essential	for	the	activation	of	the	meiotic	checkpoint	(Abdu	et	al.,	2007).	The	
expression	of	Frost	gene	is	essential	for	cold	tolerance	in	Drosophila	melanogaster	and	
 
Results 
56 
 
may	play	an	important	role	in	thermal	adaptation	(Colinet	et	al.,	2010).	The	analysis	
of	mRNA	in	ada2bd842	null	animals	containing	pUAS‐dAda2a2b	transgene	revealed	no	
significant	 changes	 in	 the	 expression	 levels	 of	 the	 selected	 genes	 compared	 to	 the	
wild	type	(Fig.	4.13).		
 
Fig.	4.13	The	mRNA	 levels	of	Hus1‐like,	Fst,	Sug	and	Cnc	 in	ada2bd842	mutant	and	dAda2a2b	
hybrid	expressing	transgenic	white	pupae.	The	changes	in	gene	expression	were	determined	by	
real‐time	 PCR	 and	 compared	 to	wild‐type	 represented	 by	 the	 blue	 line.	Error	 bars	 represent	
standard	deviations	calculated	from	three	independent	experiments.	
Previous	 microarray	 studies	 have	 indicated	 that	 dATAC	 is	 required	 for	
transcriptional	activation	of	the	Halloween	genes	which	are	involved	in	the	synthesis	
of	 steroid	 hormone	 ecdysone	 critical	 for	 molting	 and	 metamorphosis	 of	 insects	
(Pankotai	 et	 al.,	 2010).	 In	 order	 to	 explore	 whether	 the	 altered	 mRNA	 levels	 of	
Halloween	 genes	 in	 ada2ad189	 null	 mutants	 can	 be	 changed	 by	 expressing	 pUAS‐
dAda2bS2a	or	pUAS‐dAda2bM2a	chimeric	transgenes,	we	carried	out	Quantitative	Real	
Time	 PCR.	 Among	 the	Halloween	 genes	 we	 chose	 to	 analyse	 Phm	 (phantom),	 Spok	
(spookier)	 and	 Sad	 (shadow)	 which	 were	 found	 to	 be	 downregulated	 in	 ada2ad189	
mutants	 (Pankotai	 et	 al.,	 2010).	The	Phm	 gene	 encodes	 a	25‐hydroxylase,	Sad	 gene	
encodes	 the	 2‐hydroxylase	 and	 Spok	 gene	 is	 believed	 to	 be	 important	 for	 a	 yet	
uncharacterized	step	(the	Black	Box)	in	the	biosynthesis	of	ecdysone	hormone	(Ono	
et	 al.,	 2006;	 Rewitz	 et	 al.,	 2006).	 The	 Quantitative	 Real‐Time	 PCR	 assay	 did	 not	
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indicated	 any	 significant	 change	 in	 the	mRNA	 level	 corresponding	 to	 either	 of	 the	
above	 mentioned	 genes	 in	 the	 chimeric	 transgenes‐carrier	 dATAC	mutant	 animals	
compared	 to	 ada2d189	 null	 mutants	 (Fig.	 4.14).	 The	 failure	 to	 detect	 any	 change	 in	
mRNA	level	of	the	selected	genes	in	either	one	or	the	other	ada2	mutants	expressing	
chimeric	transgenes	might	be	the	result	of	the	partial	rescue.		
 
Fig.	4.14	Expression	of	Halloween	genes	in	ada2ad189	mutant	and	the	effect	of	hybrid	transgenes	
on	 mRNA	 levels.	 The	 changes	 in	 gene	 expression	 were	 determined	 by	 real‐time	 PCR	 and	
compared	 to	wild‐type	 represented	by	 the	blue	 line.	Error	bars	 represent	 standard	deviations	
calculated	from	three	independent	experiments.	
4.5 In	vivo	interaction	between	dADA2b	isoforms,	dADA3	and	dp53	
The	dAda2b	gene	in	Drosophila	melanogaster	gives	rise	to	two	protein	isoforms	
designated	 as	 dADA2bS	 (short	 isoform)	 and	 dADA2bL	 (long	 isoform).	 Previous	
biochemical	 separation	 of	 GCN5‐containing	 complexes	 have	 identified	 dADA2b	
proteins	 with	 different	 molecular	 masses	 in	 fractions	 corresponding	 to	 1,8‐2	 MDa	
complexes	(Muratoglu	et	al.,	2003).	The	presence	of	two	dADA2b	isoforms	and	their	
co‐fraction	with	subunits	of	dSAGA	HAT	complex	might	suggest	that	the	short	and	the	
long	 dADA2b	 isoforms	 are	 subunits	 of	 either	 the	 same	 or	 similar	 multiprotein	
complexes.		
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The	two	dADA2b	isoforms	are	identical	in	their	N‐terminal	330	aa	region.	These	
segments	of	the	proteins	harbour	a	ZZ	zinc	finger	and	a	SANT	domain,	characteristic	
for	all	known	ADA2	proteins,	and	two	so‐called	ADA	boxes	(Muratoglu	et	al.,	2003).	
The	 dADA2L	 protein	 has	 an	 extra	 ADA	 box	within	 the	 C‐terminal	 region.	 Although	
there	is	no	similarity	between	dADA2bL	and	dADA2bS	at	their	C‐terminal	regions	(Qi	
et	 al.,	 2004),	 a	 sequence	at	 the	3′	 segment	of	dADA2bL	 (corresponding	 to	50	aa)	 is	
also	present	in	two	putative	human	hADA2b	proteins.	However,	the	SWIRM	domain	
characteristic	 for	 the	 C‐terminal	 region	 of	 human	 ADA2b	 proteins	 could	 not	 be	
recognized	in	the	Drosophila	counterparts.		
It	 is	 well	 established	 that	 ADA2	 proteins	 are	 components	 of	 multiprotein	
complexes	 and	 participate	 in	 protein‐protein	 interactions.	 The	 occurrence	 of	 two	
dADA2b	protein	 isoforms	 in	Drosophila	 raised	 the	 intriguing	possibility	of	different	
protein‐protein	 interaction	 patterns.	 Thus,	 we	 performed	 experiments	 to	 analyse	
whether	 the	 two	 isoforms	 can	 interact	with	 each	other	 and	whether	both	proteins,	
dADA2bS	 and	 dADA2bL,	 can	 interact	 with	 dADA3	 protein,	 another	 component	 of	
ADA2b‐containing	HAT	complexes.		
To	 detect	 protein‐protein	 interactions	N‐terminal	 FLAG	 or	HA	 epitope	 tagged	
dADA2b	 isoforms	 were	 transiently	 expressed	 in	 S2	 cells.	 Whole‐cell	 lysates	 were	
obtained	 and	 incubated	 with	 M2	 (anti‐FLAG)	 agarose	 beads.	 Immunoprecipitates	
were	 analysed	 by	 immunoblotting	 using	 epitope‐specific	 antibodies.	 Co‐
immunoprecipitation	 of	 dADA2bS	 with	 dADA2bL	 and	 vice	 versa	 indicated	 in	 vivo	
physical	interaction	between	the	two	isoforms	(Fig.	4.15	A	and	B).		
 
Fig.	 4.15	 In	 vivo	 interaction	 between	 dAda2b	 isoforms.	 Cells	 were	 co‐transfected	 with	 the	
indicated	 constructs	 for	 immunoprecipitation	 (on	 the	 left	 and	 upper	 part).	 (A)	 The	 FLAG‐
dAda2bL	immunoprecipitated	with	HA‐dAda2bS.	(B)	In	a	reciprocal	experiment	FLAG‐dAda2bS	
co‐immunoprecipitated	with	HA‐dAda2bL.	
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To	further	analyse	the	possibility	that	the	two	isoforms	are	components	of	the	
same	 or	 related	 multiprotein	 complexes	 we	 performed	 co‐immunoprecipitation	
experiments	 to	 determine	 whether	 the	 two	 dADA2b	 isoforms	 can	 interact	 with	
dADA3,	one	of	the	dSAGA	subunits.	Using	anti‐FLAG	M2	agarose	beads	we	confirmed	
the	 association	 of	 the	 short	 and	 long	 dADA2b	 isoforms	 with	 dADA3	 protein	
(Fig.	4.16	A).	 Together,	 the	 result	 from	 the	 co‐immunoprecipitation	 experiments	
opens	 the	 possibility	 that	 both	 dADA2b	 isoforms	 are	 components	 of	 the	 same	 or	
similar	HAT	complexes.		
 
Fig.	 4.16	 In	 vivo	 interaction	 between	 dAda2b	 isoforms,	 dAda3	 and	 dp53.	 (A)	 Both	 dAda2b	
isoforms	 co‐immunoprecipitated	with	HA‐dAda3.	 (B)	 The	 FLAG‐dAda2bL	 and	 FLAG‐dAda2bS	
immunoprecipitated	with	HA‐dp53.	The	antibodies	used	for	developing	the	blots	are	shown	on	
the	right.	
Previous	 studies	 in	 human	 cells	 have	 demonstrated	 that	 the	 transcriptional	
activity	of	the	tumour	suppressor	p53	requires	the	ADA2/ADA3/GCN5	HAT	complex	
(Wang	et	al.,	2001).	Moreover,	mutations	of	the	dAda2b	gene	affected	dp53	function	
(Pankotai	et	al.,	2005),	and	a	physical	interaction	between	dADA2b	and	dp53	was	also	
shown	(Kusch	et	al.,	2003).	Based	on	these	observations	we	found	interesting	to	learn	
if	 dADA2b	 isoforms	 displayed	 differences	 in	 interaction	 with	 dp53.	 To	 determine	
whether	 dADA2b	 isoforms	 can	 associate	 with	 the	 tumour	 suppressor	 dp53	 we	
performed	 anti‐FLAG	 co‐immunoprecipitation	 and	 probed	 the	 Western	 blots	 with	
antibodies	against	HA‐dp53.	We	observed	that	both	dADA2bS	and	dADA2bL	isoforms	
co‐immunoprecipitated	with	dp53	 (Fig.	4.16	B).	This	 suggests	 that	 the	 two	dADA2b	
isoforms	might	participate	in	different	dp53‐mediated	pathways.	
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The	 data	 obtained	 from	 the	 co‐immunoprecipitation	 experiments	 did	 not	
reveal	 different	 abilities	 of	 the	 two	 dADA2b	 isoforms	 to	 participate	 in	 protein	
interactions,	 but	demonstrated	 the	possibility	of	dimer	 formation	between	dADA2b	
isoforms.	Furthermore,	 the	 two	dADA2b	 isoforms	demonstrated	 the	same	ability	 to	
interact	with	the	dADA3	adaptor	protein	and	the	tumour	suppressor	dp53.		
 61 
 
 	Chapter 5.
Discussion	
A	 considerable	 number	 of	 transcriptional	 regulatory	 proteins	 have	 been	
identified	 to	 interact	with	 and	 alter	 chromatin.	 They	display	 remarkable	 specificity	
regarding	 their	 histone	 selectivity	 and	 capacity	 to	 distinguish	 specific	 nucleosome	
substrates.	How	do	 proteins	 that	 alter	 chromatin	 structure	 accomplish	 preferential	
affinity	to	specific	substrates	represents	an	important	mechanistic	issue.	One	relevant	
aspect	 of	 ATP‐dependent	 chromatin	 remodelling	 enzymes	 and	 histone	 modifying	
proteins	is	the	fact	that	they	function	as	large	complexes	and	that	their	specificity	is	
given	 in	 part	 by	 these	 assemblies.	 There	 are	 two	 important	 aspects	 to	 consider	
regarding	 the	 specificity	 of	 a	 complex.	 First,	 the	 domains	 within	 the	 enzymes	
themselves	are	necessary	for	targeting	the	complexes	to	nucleosomes,	as	exemplified	
by	 GCN5	 bromodomain	 proven	 to	 be	 essential	 for	 nucleosome	 acetylation	 as	 a	
subunit	of	SAGA	complex	(Sterner	et	al.,	1999).	The	second	feature	to	consider	is	the	
presence	 of	 several	 interacting	 proteins	 which	 can	 influence	 the	 specificity	 of	 the	
complexes.	 For	 instance,	 TAFII68	 is	 required	 for	 SAGA‐dependent	 acetylation	 of	
nucleosomes.		
In	 this	 dissertation,	 according	 to	 the	 results	 obtained	 from	 the	 rescue	
experiments	and	the	chromosome	immunostainings	we	propose	that	the	C‐terminal	
region	within	 the	dADA2	chimeric	proteins	 is	essential	 for	selectively	 incorporating	
the	chimeras	into	one	or	the	other	HAT	complex.	Although	we	did	not	perform	HAT	
complex	purifications	the	combined	data	strongly	suggests	that	the	chimeric	proteins	
can	 partially	 substitute	 the	 function	 of	 dADA2a	 or	 dADA2b	 proteins	 as	 subunits	 of	
dATAC	 or	 dSAGA	 HAT	 complexes	 which	 in	 turn	 determines	 H3‐	 or	 H4‐specific	
targeting.	
The	D.	melanogaster	 dATAC	 and	 dSAGA	 complexes	 share	 dGCN5	 and	 dADA3	
subunits,	but	differ	 in	containing	one	of	two	complex‐specific	dADA2	type	adaptors.	
Genetic	analysis	revealed	that	mutations	removing	dADA2b	from	dSAGA	results	in	a	
decrease	in	histone	H3K9ac	and	H3K14ac	levels	(Qi	et	al.,	2004;	Pankotai	et	al.,	2005).	
Mutations	 affecting	 the	 dATAC	 subunit	 dADA2a	 result	 in	 decreased	 H4K5ac	 and	
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H4K12ac	levels	(Pankotai	et	al.,	2005;	Ciurciu	et	al.,	2006;	Guelman	et	al.,	2006).	Thus,	
the	presence	of	dADA2a	or	dADA2b	adaptor	proteins	in	a	complex	correlates	with	the	
histone	 specificity	 of	 that	 complex.	 However,	 in	 addition	 to	 dGCN5	 (KAT2),	 dATAC	
harbours	 at	 least	 one	 additional	 subunit	 with	 HAT	 activity.	 dATAC2	 (KAT14)	 was	
identified	to	act	as	a	second	acetyltransferase	enzyme	of	the	dATAC	complex	with	a	
preference	 for	 acetylating	 histone	 H4	 (Suganuma	 et	 al.,	 2008).	 Mutations	 of	 Atac2	
resulted	 in	 a	 drop	 of	 H4K16ac	 levels	 in	 late	 embryos.	 The	 L2	 lethality	 of	 atac2	
mutants	 prevented	 studying	 the	 effect	 of	 this	 HAT	 on	 the	 acetylation	 of	 polytene	
chromosomal	histones.	Both	dSAGA	and	dATAC	seem	to	be	involved	in	global	as	well	
as	 promoter‐specific	 histone	 modifications.	 Furthermore,	 in	 addition	 to	 its	 HAT	
activities	SAGA	plays	a	role	in	chromatin	regulation	via	a	deubiquitination	module	as	
well	 (Weake	et	 al.,	 2008;	Zhao	et	 al.,	 2008).	All	 the	 above	 illustrates	 a	high	 level	 of	
interest	in	exploring	molecular	interactions	determining	SAGA	and	ATAC	functions.		
Previous	 studies	 have	 shown	 that	 distinct	 phenotypes	 arise	 from	 the	 loss	 of	
Drosophila	dAda2a	or	dAda2b	functions.	Earlier	results	from	our	laboratory	combined	
with	data	of	others,	established	the	complex‐specific	nature	of	dADA2a	and	dADA2b.	
As	a	further	extension	of	those	studies	this	dissertation	work	demonstrated	that	the	
C‐terminal	 regions	 of	 both	 dADA2	 proteins	 seem	 to	 play	 determining	 roles	 in	
complex‐specific	 integration.	 Chimeric	 dADA2	 proteins	 integrate	 into	 distinct	 HAT	
complexes	depending	on	their	C‐terminal	domains,	which	based	on	the	in	vivo	rescue	
ability	and	in	accordance	with	the	histone	acetylating	activity,	these	complexes	can	be	
assumed	 of	 being	 in	 fact	 dSAGA	 and	 dATAC.	 We	 constructed	 chimeric	 dADA2	
adaptors	by	switching	the	more	conserved	N‐terminal	and	less	preserved	C‐terminal	
regions	 between	 dADA2a	 and	 dADA2b.	 Three	 out	 of	 four	 tested	 constructs	 gave	
positive	 results	 in	 causing	 partial	 rescue	 of	 developmental	 defects	 in	 vivo	 and	
acetylating	histones	that	were	decreased	due	to	ada2ad189	or	ada2bd842	mutation.	We	
assume	that	proper	folding	of	these	dADA2	proteins	permitted	the	incorporation	into	
dSAGA	or	dATAC	complexes	leading	to	partial	recovery	of	functions.		
Sequence	comparisons	and	functional	assays	of	ADA2	proteins	identified	three	
regions	 that	 are	 believed	 to	 mediate	 important	 functions.	 In	 yeast,	 in	 vitro	
experiments	 indicated	 that	 the	 N‐terminal	 ZZ	 finger	motif	 of	 ADA2	 protein	 has	 an	
essential	 role	 in	 interacting	with	GCN5	 (Candau	 and	Berger,	 1996).	 Deletion	 of	 the	
SANT	domain	attenuated	the	capacity	of	yeast	ADA2	to	support	in	vivo	transcriptional	
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activity	 (Candau	 and	 Berger,	 1996).	 The	 yADA2	 SANT	 domain	 potentiated	 the	
catalytic	 function	of	yGCN5	and	was	important	 for	acetylating	nucleosomal	histones	
(Balasubramanian	et	al.,	 2002;	Sterner	et	 al.,	 2002).	The	 region	 following	 the	SANT	
domain	was	shown	to	interact	with	yADA3	 in	vitro	 (Berger	et	al.,	1992;	Candau	and	
Berger,	1996;	Candau	et	al.,	1996).	A	less	conserved	region	among	ADA2	proteins	is	
the	SWIRM	domain.	Studies	on	mammalian	ADA2b	protein	revealed	a	conditional	role	
of	the	SWIRM	domain	in	chromatin	acetylation	by	STAGA	(Gamper	et	al.,	2009).	Our	
structure	comparison	revealed	no	SWIRM	domain	 in	dADA2b,	while	 it	 is	present	 in	
dADA2a	(Fig.	5.1).	In	this	respect	the	two	ADA2	factors	of	D.	melanogaster	differ	more	
than	ADA2	proteins	of	other	metazoa.		
 
Fig.	5.1	 Sequence	alignment	of	 the	 SWIRM	domains.	The	 secondary	 structure	prediction	was	
performed	using	PRALINE	Multiple	Sequence	Alignment	 (Heringa,	1999,	2000,	2002;	Simossis	
and	Heringa,	2003;	Pirovano	et	al.,	2008).	The	proteins	are	designated	by	their	names	followed	
by	 species	abbreviations.	Each	 sequence	 segment	 is	 flanked	by	 the	coordinates	of	 its	 first	and	
last	 amino	 acid.	 The	 proposed	 secondary	 structure	 elements	 in	 the	 predicted	 models	 are	
specified	 above	 the	 protein	 alignment	 (barrel	 shape	 figure	 representing	 the	 α‐helix).	 The	
highlighted	 residues	 in	 the	proteins	 represent	 the	predicted	 secondary	 structure	 (red	 ‐	alpha	
helix;	 blue	 ‐	 beta	 strand).	 The	 species	 listed	 are:	 Hs,	 Homo	 sapiens;	 Dm,	 Drosophila	
melanogaster;	Sc,	Saccharomyces	cerevisiae.	The	NCBI	Reference	sequences	are	 the	 following:	
NP_001479.3,	NP_001014636.1,	NP_010736.1,	NP_689506.2,	NP_001027151.1,	NP_649773.1.	
In	 this	 dissertation	 it	 is	 demonstrated	 that	 the	 C‐terminal	 region	 seems	 to	
determine	 the	 targeting	 of	 dADA2	 proteins	 into	 GNAT	 complexes	 which	 differ	 in	
specificity	 to	 acetylate	 histone	 H3	 or	 H4.	 Data	 on	 the	 physical	 and	 functional	
interaction	of	ADA2	proteins	 and	other	 subunits	within	HAT	 complexes	 are	mostly	
from	studies	performed	on	yeast	and	human	SAGA.	These	complexes	are	thought	to	
be	 built	 from	 structural	 and	 functional	modules	with	 poorly	 defined	 independence	
(Samara	and	Wolberger,	2011).	The	SAGA	HAT	module	consists	of	GCN5,	ADA3,	ADA2	
and	 SGF29.	 Detected	 physical	 interactions	 place	 ADA2	 between	 GCN5	 and	 ADA3.	
SGF29	makes	 contact	with	ADA3.	Human	ADA2	 interacts	with	ADA3	 through	 its	N‐
terminal	region	following	the	SANT	domain	and	its	C‐terminal	SWIRM	domain	while 
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contacts	with	GCN5	are	made	 through	 the	SANT	domain	(Gamper	et	al.,	2009).	The	
homologous	 regions	 were	 found	 to	 be	 required	 for	 yeast	 ADA2	 and	 ADA3/GCN5	
interactions	as	well	(Candau	and	Berger,	1996;	Sterner	et	al.,	2002).	Yeast	two‐hybrid	
experiments	 detected	physical	 interactions	 of	 dADA2	both	with	 dADA3	 and	dGCN5	
(Ciurciu	et	al.,	2006).		
At	present,	limited	amount	of	data	are	available	on	the	physical	and	functional	
relations	between	the	HAT	module	and	the	rest	of	the	SAGA	(Suganuma	et	al.,	2008;	
Lee	et	al.,	2011).	It	is	important	to	note	here	that	physical	interactions	of	ADA2b	and	
ADA3	 have	 also	 been	 detected	 with	 several	 non‐SAGA	 subunit	 transcription	
regulators,	for	example	the	p53	tumour	suppressor	among	others.	Furthermore,	it	is	
also	 noteworthy	 that	 dADA2b	 give	 rise	 to	 two	 isoforms	 which	 differ	 in	 their	 C‐
terminal	regions	(Muratoglu	et	al.,	2003).	Biochemical	purification	of	HAT	complexes	
eluted	two	dADA2b	isoforms	in	the	same	fraction	(Muratoglu	et	al.,	2003;	Pankotai	et	
al.,	 2013a).	However,	 a	 considerable	 difference	 between	dAda2b	 isoforms	 has	 been	
detected	 in	 the	message	and	protein	 levels	during	 fly	development	 (Pankotai	 et	 al.,	
2013a).		
All	 the	 above	 observations	 made	 us	 wonder	 whether	 different	 dSAGA	
complexes	 exist,	 in	 respect	 of	 their	 dADA2b	 content,	 or	 different	 dADA2b	 protein	
isoforms	 are	 present	 in	 the	 same	 complexes.	 Considering	 that	 SAGA	 possesses	
multiple	activities	in	different	biological	processes	(Weake	and	Workman,	2012)	we	
can	hypothesize	 that	 a	 slight	 change	of	 subunit	 composition	within	 the	 functionally	
independent	modules	can	influence	the	activity	of	SAGA.	In	this	respect	we	consider	
the	 isoforms	 of	 dADA2b	protein	 as	 good	 candidates	 for	 having	 that	 particular	 role.	
According	 to	 co‐immunoprecipitation	 experiments	 dADA2b	 isoforms	 can	 form	
dimers	 (Fig.	4.15	A	and	B).	 In	addition,	both	dADA2bS	and	dADA2bL	 isoforms	have	
been	found	to	co‐immunoprecipitate	with	dADA3	in	Drosophila	S2	cells	(Fig.	4.16	A).	
Thus,	the	experimental	data	suggest	that	either	of	the	two	isoforms	can	participate	as	
subunits	 of	 the	HAT	module	within	 dSAGA	 complex.	 The	 partial	 phenotypic	 rescue	
observed	 during	 analysing	 the	 in	 vivo	 function	 of	 dADA2bS	 isoform	 transgene	
indicates	that	the	shorter	product	alone	can	complement	to	some	extend	the	dSAGA	
functions	required	for	completing	the	fly	development	(Pankotai	et	al.,	2013a).		
In	 a	 mammalian	 system	 it	 was	 shown	 that	 the	 GCN5‐containing	
acetyltransferase	 complex	 (STAGA)	 plays	 a	 role	 in	 p53‐dependent	 gene	 activation.	
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ADA2b	 and	 GCN5	 proteins	 are	 direct	 interacting	 partners	 of	 the	 p53	 transcription	
factor	(Gamper	and	Roeder,	2008).	According	to	previous	studies	Drosophila	p53	is	a	
functional	homologue	of	mammalian	p53	(Ollmann	et	al.,	2000).	Physical	interaction	
has	 been	 demonstrated	 between	 dADA2b	 and	 dp53	 and	 loss	 of	 dAda2b	 function	
contributes	to	p53‐dependent	apoptosis	in	response	to	gamma	radiation	(Kusch	et	al.,	
2003;	 Qi	 et	 al.,	 2004).	 Even	 though	 only	 the	 animals	 carrying	 the	 short	 dADA2b	
isoform	displayed	reduced	 level	of	apoptosis	 in	response	to	DNA	damage	caused	by	
irradiation	 (Pankotai	 et	 al.,	 2013a),	 both	 dADA2b	 isoforms	 interacted	 with	 dp53	
(Fig.	4.16	B).	Thus,	it	appears	that	dADA2b	may	be	necessary	for	efﬁcient	DNA	repair	
or	 generation	 of	 a	 DNA	 damage	 signal	 and	 the	 interaction	 with	 dp53	 might	 be	
required	as	an	intermediary	step	along	the	complex	apoptosis	pathway.		
Information	on	 the	structural	organization	of	ATAC	 is	more	scarcely	available.	
Since	ATAC	contains	 three	of	 the	subunits	present	 in	 the	HAT	module	of	SAGA,	and	
CG30390,	a	protein	related	to	yeast	SGF29	identified	during	dATAC	subunit	analysis	
(Suganuma	et	al.,	2008),	one	would	expect	the	existence	of	a	dGCN5‐containing	HAT	
module	 in	 dATAC,	 built	 similarly	 to	 that	 of	 dSAGA.	 The	 detected	 interactions	 of	
dADA2a	 both	with	 dGCN5	 and	 dADA3	might	 give	 support	 to	 this	 assumption.	 This	
leads	 to	 the	 question	whether	 the	 histone	H4K5	 and	K12	 acetyltransferase	 activity	
can	be	attributed	to	dGCN5	or	to	dATAC2.	A	third	possibility	could	be	that	neither	of	
these,	but	other	HAT(s)	which	are	affected	by	mutations	of	dATAC	subunits	are	 the	
underlying	cause	of	the	decrease	in	H4	acetylation.	It	is	highly	plausible	that	the	loss	
of	 dADA2a	 disrupts	 the	 complex	 or	 distorts	 it	 in	 a	 way	 that	 inactivates	 dATAC2.	
Reduced	 acetylated	 histone	 H4	 levels	 in	 ada2ad189	 mutants	 might	 result	 from	
knocking	out	the	activity	of	the	dGCN5	module.		
Several	observations	can	be	put	forward	to	argue	for	a	direct	role	of	dGCN5	in	
H4K5	 and	 K12	 modifications.	 First,	 dATAC2	 was	 found	 to	 be	 specific	 for	 histone	
H4K16.	Altered	H4K16ac	 levels	were	never	observed	 in	ada2ad189	mutants.	 Second,	
gcn5E333st	 mutants	 and	 ada2ad189	 mutants	 display	 practically	 identical	 phenotypes	
with	 respect	 to	 both	 developmental	 failures	 and	 reduced	 H4K5ac/K12ac	 levels.	
Actually,	the	loss	of	the	third	component	of	the	dGCN5‐centered	HAT	module,	dADA3	
caused	similar	changes	(Grau	et	al.,	2008).	Importantly,	dGcn5	allele	altered	either	in	
the	HAT	or	the	ADA2	interacting	region	of	the	protein	(Carre	et	al.,	2005)	also	showed	
identical	phenotypes	with	ada2ad189	null	mutants,	 and	genetic	 interactions	between	
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ada2ad189	 and	 gcn5E333st	 mutants	 have	 been	 demonstrated	 in	 different	 settings	
(Ciurciu	 et	 al.,	 2006).	Taken	 together,	 the	possibility	 that	 dGCN5	acts	 on	H4K5	and	
K12	side	chains	as	a	catalytic	unit	within	the	dATAC	complex	can	hardly	be	excluded,	
though	it	can	neither	be	proven	by	direct	evidence.	The	observed	loose	specificity	of	
dGCN5	 and	 its	 reduced,	 but	 still	 existing	 affinity	 towards	H4	 gives	 support	 for	 this	
possibility.		
Analyses	of	the	functional	consequences	of	yeast	and	human	ADA2‐ADA3‐GCN5	
interactions	 concluded	 that	 GCN5	 activity,	 and	 significantly,	 its	 affinity	 towards	
histones	depended	upon	the	context	the	enzyme	was	positioned	and	also	the	context	
of	its	substrate	(Grant	et	al.,	1999;	Balasubramanian	et	al.,	2002;	Sterner	et	al.,	2002;	
Gamper	 et	 al.,	 2009).	 Tetrahymena	 GCN5	 can	 accept	 histone	 H4	 side	 chains	 as	
substrates	 (Poux	 and	Marmorstein,	 2003)	 and	 yGcn5	mutations	 cause	 reduced	 H4	
acetylation	 (Zhang	 et	 al.,	 1998).	 Therefore,	 within	 ATAC,	 a	 GCN5	 containing	 HAT	
module	could	be	in	suitable	conformation	for	H4K5	and	K12	acetylation	Alternatively,	
ATAC2	enzymatic	activity	might	be	affected	by	ADA2a	 loss	of	 function.	However,	 in	
Drosophila,	different	lethal	phases	of	ada2ad189	and	atac2	mutants	do	not	support	this	
assumption.	Atac2	mutants	 are	 L2	 lethal,	while	ada2ad189	 lethal	 phase	 is	 late	 L3.	 If	
indeed	 the	 product	 of	 ada2ad189	 is	 required	 for	 dATAC2	 function,	 than	 one	 would	
expect	 identical	phenotypes.	A	 counter	argument	 to	 this	 can	be	based,	however,	on	
different	 amount	 of	 the	maternal	 gene	products.	 Interplay	 between	units	 of	 dATAC	
could	 target	 the	 complex	 to	 chromatin	via	dGCN5	bromodomain	 interactions,	while	
H4	 acetylation	 is	 performed	by	dATAC2.	 In	 this	 respect	 the	difference	between	 the	
two	dADA2	proteins	in	having	or	not	having	a	SWIRM	domain,	which	has	chromatin	
binding	affinity,	might	bear	significance.		
Regarding	the	question	whether	ada2ad189	mutations	disable	dGCN5	or	dATAC2	
(or	 both)	 to	 acetylate	 H4K5	 and	 K12	 residues,	 it	 was	 shown	 that	 the	 H4	 specific	
acetylation	 is	 partially	 restored	 in	 ada2ad189	 mutants	 by	 chimeric	 transgenes	
expressing	dADA2a	C‐terminal	region	fused	to	N‐terminal	of	dADA2b.	The	acetylation	
extends	all	 over	 the	polytene	 chromosomes.	 Similarly,	 the	partial	 rescue	of	 dSAGA‐
specific	 H3	 acetylation	 by	 dADA2a/2b	 chimeric	 transgene	 expression	 seems	 to	 be	
more	of	 a	global	 than	a	 gene	 specific	modification	 change.	The	 restored	acetylation	
levels	 in	 neither	 case	 correlated	with	 restored	mRNA	 levels	 concerning	 the	 limited	
number	of	genes	we	tested	by	qPCR.	This	can	be	the	result	of	the	partial	rescue,	or	it	
 
Discussion 
67 
 
could	reflect	a	less	direct	link	between	these	histone	acetylation	and	gene	expression	
changes.		
Acetylation	 of	 H4K5	 and	 K12	 is	 linked	 to	 histone	 deposition	 into	 newly	
synthesized	 chromatin	 during	 S	 phase	 (Sobel	 et	 al.,	 1995).	 Among	 the	 identified	
Drosophila	 HATs	 (Chameau,	 Tip60,	 Enok	 (enoki	 mushroom),	 CBP	 (nejire),	 ELP3),	
several	 have	 been	 shown	 to	 target	 these	 side	 chains	 of	 H4	 (Allis	 et	 al.,	 2007).	 Our	
laboratory	 recently	 reported	 microarray	 data	 on	 the	 transcriptome	 of	 ada2ad189	
mutants	(Pankotai	et	al.,	2010).	In	these	mutants	down‐regulated	mRNA	levels	were	
detected	corresponding	to	HAT,	HDAC	and	histone	chaperone	genes	at	late	L3	stage,	
when	 a	 global	 decrease	 in	 K5	 and	 K12	 acetylated	H4	 on	 polytene	 chromosomes	 is	
clearly	observable	(Table	5.1).	The	decreased	mRNA	levels	are	unlikely	to	be	caused	
by	an	unspecific	RNA	degradation	since	other	genes,	among	them	several	involved	in	
acetyl‐CoA	 metabolism,	 are	 represented	 by	 elevated	 mRNA	 levels	 as	 compared	 to	
wild	 type.	 Moreover,	 strong	 correlation	 exists	 between	 expression	 changes	 in	
ada2ad189	and	ada32	mutants.	Strikingly,	dGCN5	(KAT2)	stands	out	being	represented	
by	 an	 increased	 mRNA	 level	 in	 dATAC	 subunit	 mutants	 (Table	 5.1).	 Based	 on	 the	
microarray	data	one	 can	hypothesize	 that	 a	perturbed	balance	of	HATs	and	HDACs	
leads	to	the	global	H4	acetylation	changes	in	dATAC	mutants.	These	indirect	effects	of	
dATAC	mutations	might	cover	gene	specific	alterations	caused	directly	either	by	the	
dGCN5	or	dATAC2	catalytic	unit	of	dATAC	complex.		
The	 results	 reported	 within	 this	 dissertation	 are	 in	 accord	 with	 previously	
collected	genetic	data	and	underline	the	differences	 in	histone	specificity	of	the	two	
Drosophila	 GCN5‐containing	 HAT	 complexes.	 The	 demonstration	 of	 the	 important	
contribution	of	dADA2	C‐terminal	regions	to	complex	formation	pose	questions	and	
open	ways	 to	 follow	 in	 the	exploration	of	 subunit	 interactions	 in	order	 to	elucidate	
the	roles	of	these	GCN5‐containing	complexes	in	chromatin	regulation.		
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Table	5.1	Expression	changes	of	selected	genes	in	ada2ad189	and	ada32	null	mutants.	
Classification	 Gene	symbol	 Gene	accession	number	
log2	expression	change	
Biological	function	
ada2ad189	 ada32	
Histone	
acetyltransferases	
Gcn5	(KAT2)	 CG4107‐RA 1.44 0.70 histone	acetyltransferase	activity
Atac2	(KAT14)	 CG10414‐RA	 ‐0.50 ‐0.33 N‐acetyltransferase	activity
ELP3	(KAT9)	 CG15433‐RA 0.09 0.49 histone	acetyltransferase	activity
HAT1	(KAT1)	 CG2051‐RC ‐1.08 ‐0.99 histone	acetyltransferase	activity
Chm	(KAT7)	 CG5229‐RA ‐2.14 ‐0.95 histone	acetyltransferase	activity
MOF	(KAT8)	 CG3025‐RA	 ‐0.02 0.48 histone	acetyltransferase	activity
Enok	(KAT6A)	 CG11290‐RA	 ‐1.15 ‐0.40 histone	acetyltransferase	activity
Tip60	(KAT5)	 CG6121‐RA	 ‐0.80 ‐0.78 histone	acetyltransferase	activity
CG1894	(KAT6)	 CG1894‐RA ‐1.26 ‐1.66 protein	amino	acid	acetylation
Nej	(CBP)	 CG15319‐RB ‐0.93 ‐0.79 histone	acetyltransferase	activity
Histone		
Deacetylases	
HDAC3	 CG2128‐RA	 ‐1.03 ‐0.88 histone	deacetylase	activity	
HDAC4		 CG1770‐RA	 ‐0.77 ‐0.42 histone	deacetylase	activity
Rpd3	HDAC	 CG7471‐RA	 ‐2.00 ‐1.94 histone	deacetylase	activity;
Sir2	HDAC	 CG5216‐RA ‐0.93 ‐0.47 NAD‐dependent	histone	deacetylase	activity
Sirt2	HDAC	 CG5085‐RA ‐0.10 0.11 NAD‐dependent	histone	deacetylase	activity
Histone		
Chaperones/	
nucleosome	
assembly	
Ash1	 CG8887‐RA ‐1.34 ‐0.85 histone	chaperone
Nap1	 CG5330‐RA	 0.58 0.56 nucleosome	assembly;	histone	binding
Nlp	 CG7917‐RA	 ‐0.17 ‐0.11 histone	binding;	ATPase	activity
Caf1	 CG4236‐RA	 ‐0.93 ‐0.85 histone	acetyltransferase	binding
Acetyl‐CoA	metabolism	
CG11198	 CG11198‐RA 2.65 2.87 acetyl‐CoA	carboxylase	activity	
AcCoAS	 CG9390‐RA 1.26 1.61 acetate‐CoA	ligase	activity
CS	 CG3861‐RB	 1.42 1.39 citrate	(Si)‐synthase	activity
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Summary	
In	eukaryotes,	the	association	of	the	genomic	DNA	with	histone	and	non‐histone	
proteins	 into	 chromatin	 provides	 the	 means	 for	 compaction	 of	 the	 entire	 genome	
inside	 the	 nucleus.	 However,	 the	 compact	 structure	 of	 the	 chromatin	 restricts	 the	
access	to	the	DNA	for	various	regulatory	proteins	with	essential	biological	functions	
in	processes	like	transcription,	replication	and	DNA	repair.	The	repressive	nature	of	
the	 chromatin	 can	be	modulated	by	 two	mechanisms:	 covalent	modifications	of	 the	
histone	 tails	 and	 regulation	 of	 the	 chromatin	 structure	 by	 the	 ATP‐dependent	
chromatin	remodelling	enzymes.	
Histones	 are	 small	 basic	 proteins	 consisting	 of	 a	 globular	 domain	 and	 a	
flexible,	charged	amino‐	and	carboxy‐terminus	(the	histone	“tails”).	The	histone	tails	
are	 highly	 conserved	 across	 various	 species	 and	 are	 subjected	 to	 extensive	 post‐
translational	modifications	 (PTMs)	 including	 acetylation	 and	methylation	 of	 lysines	
and	arginines,	phosphorylation	of	serine	and	threonines,	ubiquitination,	sumoylation	
and	biotinylation	of	 lysines	as	well	as	ADP	ribosylation	(Dutnall	and	Ramakrishnan,	
1997).	One	of	the	most	studied	PTMs	is	the	histone	protein	acetylation.	It	is	a	highly	
dynamic	process	where	the	acetylation	of	the	lysine	residues	is	achieved	by	enzymes	
called	 histone	 acetyltransferases	 (HAT).	 However,	 the	 steady	 state	 balance	 of	 the	
histone	 acetylation	 is	 regulated	 by	 the	 opposing	 action	 of the HATs	 and	 histone	
deacetylases	(HDAC)	(Allis	et	al.,	2007;	Munshi	et	al.,	2009;	Bannister	and	Kouzarides,	
2011).		
Post‐transcriptional	modifications	of	histone	tails	serve	as	important	signals	for	
regulating	 chromatin‐related	 processes.	 Recently	 it	 has	 been	 hypothesized	 that	 the	
histone	tail	modifications	and/or	specific	combinations	of	the	covalent	modifications	
constitute	 a	 code,	 the	 “histone	 code”,	 which	 regulates	 specific	 chromatin‐related	
functions	 and	 processes	 (Jenuwein	 and	 Allis,	 2001).	 Accumulating	 studies	 on	 the	
histone	 modifications	 demonstrated	 their	 important	 role	 during	 development	 and	
emphasize	 that	 misregulation	 of	 the	 epigenetic	 mechanisms	 can	 lead	 to	 human	
disease,	including	cancer	(Furdas	et	al.,	2012).	
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Dynamic	 and	 reversible	 acetylation	 of	 histone	 octamer	 N‐terminal	 tails	 is	
strongly	 correlated	 with	 the	 transcriptional	 activity	 of	 a	 gene	 (Turner	 and	 O'Neill,	
1995).	 Based	 on	 the	 sequence	 homology	 to	 the	 histone	 acetyltransferase	 p55	 from	
Tetrahymena	thermophilia,	the	yeast	transcriptional	adaptor	GCN5	was	identified	as	
the	first	HAT	enzyme	linked	to	transcription	activation	(Brownell	et	al.,	1996b;	Kuo	et	
al.,	 1996).	 Biochemical	 studies	 have	 identified	 that	 GCN5	 represents	 the	 catalytic	
subunit	of	several	transcriptional	coactivator	complexes	raging	from	yeast	to	humans.	
Most	 of	 the	 GCN5‐containing	 histone	 acetyltransferase	 complexes	 also	 share	
ADA2	adaptor	proteins.	In	Drosophila	melanogaster	 there	are	two	genes,	referred	to	
as	 dAda2a	 and	 dAda2b,	 encoding	 related	 dADA2	 proteins	 (Kusch	 et	 al.,	 2003;	
Muratoglu	 et	 al.,	 2003).	 Biochemical	 separation	 of	 ADA2‐containig	 Drosophila	
complexes	 indicated	 that	 dADA2a	 is	 present	 in	 a	 smaller	 complex	 (dATAC)	
responsible	for	acetylation	of	histone	H4	at	lysines	K5	and	K12	(Ciurciu	et	al.,	2006;	
Guelman	et	al.,	2006;	Suganuma	et	al.,	2008),	whereas	dADA2b	is	present	in	a	larger	
complex	(dSAGA)	which	targets	H3	K9	and	K14	for	acetylation	(Kusch	et	al.,	2003;	Qi	
et	al.,	2004;	Pankotai	et	al.,	2005).	Additionally,	 the	Drosophila	Ada2b	 gene	encodes	
two	isoforms,	dADA2bS	(short)	and	dADA2bL	(long),	which	are	 identical	 in	their	N‐
terminal,	but	differ	in	their	C‐terminal	regions	(Muratoglu	et	al.,	2003;	Qi	et	al.,	2004).	
Glycerol	 gradient	 sedimentation	 analysis	 of	 the	 Drosophila	 nuclear	 extract	 have	
identified	that	the	two	dADA2b	isoforms	showed	the	same	pattern	of	sedimentation	
in	 fractions	corresponding	 to	high	molecular	masses	 (Muratoglu	et	al.,	2003).	Thus,	
the	 composition	 and	 functional	 complexity	 of	 dSAGA	 might	 be	 influenced	 by	 the	
presence	of	two	dADA2b	isoforms.		
In	this	dissertation	several	lines	of	evidence	are	provided	for	the	role	of	the	C‐
terminal	domain	of	Drosophila	dADA2	adaptor	proteins	in	regulating	the	specificity	of	
dSAGA	or	dATAC	complexes	in	vivo.	Using	a	series	of	domain	swap	chimeras,	in	which	
different	fragments	of	dADA2b	and	dADA2a	were	mutually	exchanged,	we	examined	
the	 importance	 of	 particular	 regions	 for	 the	 specificity	 of	 the	 HAT	 complexes.	 We	
tested	 the	 in	 vivo	 functions	 of	 the	 chimeric	 dADA2	 proteins	 by	 determining	 the	
phenotypical	rescue	and	histone	modifying	abilities	of	dADA2a/dADA2b	chimeras	in	
ada2ad189	 and	 ada2bd842	 null	 mutant	 background.	We	 found	 that	 Actin‐Gal4	 driven	
expression	of	 the	 chimeric	dADA2	proteins	had	a	partial	phenotypical	 rescue	effect 
for one	 or	 the	 other	 ada2	 mutants.	 Immunostaining	 of	 Drosophila	 polytene	
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chromosomes	and	western	blot	analysis	revealed	a	significant	restoration	of	the	lost	
acetylation	on	H4K5	and	K12	or	H3K9	and	K14	 in	ada2	mutants	 carrying	 chimeric	
transgenes.	In	addition,	the	effect	of	the	dADA2b/2a	chimeric	transgenes	expressions	
was	 also	 noticeable	 on	 the	 chromosome	 structure	 of	 the	 dATAC	 mutants.	 The	
distorted	phenotype	of	chromosomes	characteristic	 for	ada2ad189	null	mutation	was	
considerably	 improved	in	mutant	animals	expressing	the	pUAS‐dAda2bS2a	or	pUAS‐
dAda2bM2a	 chimeric	 transgenes.	These	 findings	promote	 the	hypothesis	 that	 the	C‐
terminal	 domain	 of	 the	 dADA2	 proteins	 plays	 an	 important	 role	 regarding	 the	
particular	 incorporation	 of	 dADA2	 proteins	 into	 dSAGA	 or	 dATAC	 type	 complexes.	
Furthermore,	 the	 ability	 to	 use	 dADA2	 chimeric	 proteins	 to	 rescue	 and	 examine	
developmental	 processes	 provides	 a	 strategy	 for	 associating	 specific	 structural	
domain	of	dADA2	proteins	with	functional	specificity.	
Biochemical	and	genetic	evidences	 revealed	 the	existence	of	 two	 isoforms	of	
dADA2b	protein	expressed	 in	different	quantities	during	 fly	development	 (Pankotai	
et	 al.,	 2013a).	 The	 experimental	 data	 presented	 in	 this	 thesis	 establish	 that	 both	
dADA2b	proteins	 interact	with	each	other	and	co‐immunoprecipitated	from	S2	cells	
with	dADA3,	as	well	as	with	the	tumour	suppressor	dp53.	These	findings	show	that	
both	 dADA2b	 proteins	 are	 functional	 and	 support	 the	 possibility	 that	 either	 both	
dADA2bL	 and	 dADA2bS	 can	 share	 the	 same	 HAT	 complex	 or	 they	 are	 subunits	 of	
different	SAGA	complexes.	In	either	way	their	interaction	with	dp53	might	suggest	a	
role	in	the	apoptotic	pathway.			
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Összefoglaló	
Eukariótákban	 a	 genomi	 DNS	 hiszton	 és	 nem‐hiszton	 fehérjékkel	 való	
kapcsolata	 során	 kialakuló	 kromatin	 szerkezet	 biztosítja	 az	 egész	 genom	
kompaktálódását	 a	 sejtmagon	 belül.	 Ez	 a	 kompakt	 struktúra	 azonban	
megakadályozza	 számos,	 a	 transzkripcióban,	 a	 replikációban	 és	 a	 DNS‐javításban	
részt	 vevő,	 esszenciális	 funkcióval	 rendelkező	 szabályozó	 fehérje	 DNS‐hez	 való	
hozzáférését.	A	kromatin	ezen	gátló	természete	két	mechanizmussal	szabályozható:	a	
hiszton	végek	kovalens	módosításaival	és	a	kromatin	szerkezet	ATP‐függő	kromatin	
átalakító	enzimek	segítségével	történő	szabályozásával.	
A	 hisztonok	 kisméretű,	 bázikus	 fehérjék	 globuláris	 alegységgel	 és	 hajlékony,	
töltéssel	rendelkező	amino‐	és	karboxi‐terminálissal,	melyeket	“hiszton	farki	domén‐
nek”	 is	 neveznek.	 A	 hiszton	 farki	 domének	 evolúcionálisan	 erősen	 konzerváltak	 és	
sokféle	 poszt‐transzlációs	 módosításnak	 (PTM)	 vannak	 kitéve:	 a	 lizin	 és	 arginin	
oldalláncok	acetilációja	és	metilációja,	a	szerin	és	treonin	oldalláncok	foszforilációja,	a	
lizinek	 ubikvitinációja,	 SUMO‐ilációja,	 biotinizációja	 és	 ADP	 ribozilációja	 egyaránt	
megfigyelhető	 rajtuk	 (Dutnall	 and	 Ramakrishnan,	 1997).	 Az	 egyik	 legjobban	
tanulmányozott	PTM	a	hiszton	fehérjék	acetilációja.	Ez	egy	igen	dinamikus	folyamat,	
melynek	 során	 a	 lizin	 oldalláncok	 acetilációját	 speciális	 enzimek,	 az	 úgynevezett	
hiszton	acetiltranszferázok	(HAT)	végzik.	A	hiszton	acetiláció	egyensúlyi	állapotának	
fenntartását	 a	HAT‐ok	 és	 a	 hiszton	deacetiláz	 (HDAC)	 enzimek	 ellentétes	 aktivitása	
biztosítja	(Allis	et	al.,	2007;	Munshi	et	al.,	2009;	Bannister	and	Kouzarides,	2011).		
A	 hiszton	 fehérjék	 poszt‐transzkripcionális	 módosításai	 fontos	 jelként	
szolgálnak	 a	 kromatinszerkezettel	 kapcsolatos	 folyamatok	 szabályozásában.	
Feltételezik,	 hogy	 a	 hiszton	 fehérjék	 farki	 doménjeinek	 módosításai	 és/vagy	 a	
kovalens	módosítások	speciális	kombinációi	egy	kódot	(„hiszton	kód”)	alkotnak,	ami	
specifikus	 kromatin‐kapcsolt	 funkciókat	 és	 folyamatokat	 szabályoz	 (Jenuwein	 and	
Allis,	 2001).	 Számos	 eredmény	 bizonyítja	 a	 hiszton	 módosítások	 egyedfejlődésben	
betöltött	 fontos	 szerepét,	 valamint	 azt,	 hogy	 az	 epigenetikai	 mechanizmusok	
szabályozatlansága	különböző	betegségek,	mint	például	a	rák	kialakulásához	vezethet	
(Furdas	et	al.,	2012).	
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A	 hiszton	 oktamer	 N‐terminális	 farki	 domének	 dinamikus	 és	 reverzibilis	
acetilációja	erősen	összefügg	egy	adott	gén	transzkripciós	aktivitásával	(Turner	and	
O'Neill,	 1995).	 Az	 élesztő	 transzkripcionális	 adaptor	 GCN5	 fehérjéjét,	 mint	 az	 első	
HAT	 enzimet	 a	 Tetrahymena	 thermophilia	 p55	 hiszton	 acetiltranszferáz	 enziméhez	
való	 szekvencia‐homológia	alapján	azonosították	(Brownell	et	al.,	1996b;	Kuo	et	al.,	
1996).	 Biokémiai	 vizsgálatok	 igazolták,	 hogy	 a	 GCN5	 számos	 tarnszkripcionális	 ko‐
aktivátor	 komplex	 katalitikus	 alegysége.	 A	 legtöbb	 GCN5‐tartalmú	 hiszton	
acetiltranszferáz	 komplex	 ADA2	 adaptor	 fehérjéket	 is	 tartalmaz.	 Drosophila	
melanogaster‐ben	 két,	 ADA2	 fehérjét	 kódoló	 gént	 ismerünk:	 dADA2a‐t	 és	 dAda2b‐t	
(Kusch	 et	 al.,	 2003;	Muratoglu	 et	 al.,	 2003).	ADA2	 fehérjéket	 tartalmazó	Drosophila	
komplexek	biokémiai	vizsgálata	során	kimutatták,	hogy	a	dADA2a	fehérje	egy	kisebb	
komplex	(dATAC)	tagja,	mely	a	hiszton	H4	 fehérjék	 lizin	5	és	 lizin	12	acetilációjáért	
felelős	 (Ciurciu	 et	 al.,	 2006;	 Guelman	 et	 al.,	 2006;	 Suganuma	 et	 al.,	 2008),	 míg	 a	
dADA2b	 fehérje	 egy	másik,	 nagyobb	komplexben	 (dSAGA)	 található,	mely	 a	 hiszton	
H3	 lizin	 9	 és	 lizin	 14	 acetilációjában	 játszik	 szerepet	 (Kusch	 et	 al.,	 2003;	 Qi	 et	 al.,	
2004;	 Pankotai	 et	 al.,	 2005).	 A	 Drosophila	 Ada2b	 génről	 két	 fehérje	 izoforma	
képződik:	 a	 rövidebb	 dADA2bS	 és	 a	 hosszabb	 dADA2bL,	melyek	 N‐terminális	 vége	
megegyezik,	míg	a	C‐terminális	részükön	különböznek	(Muratoglu	et	al.,	2003;	Qi	et	
al.,	2004).	Drosophila	sejtmagi	extrakt	glycerol	grádiens	süllyedéses	vizsgálata	során	
megállapították,	hogy	a	két	dADA2b	izoforma	azonos	süllyedési	mintázatot	mutatott	a	
nagy	 molekulasúlyú	 frakciókban	 (Muratoglu	 et	 al.,	 2003).	 Ennélfogva	 a	 dSAGA	
komplex	összetételét	és	funkcionális	összetettségét	a	két	dADA2b	izoforma	jelenléte	
befolyásolja.		
Disszertációmban	számos	bizonyítékkal	támasztom	alá,	hogy	a	Drosophila	ADA2	
adaptor	 fehérjék	 C‐terninális	 doménje	 szerepet	 játszik	 a	 dSAGA	 vagy	 a	 dATAC	
komplex	 specifitásában	 in	 vivo.	 Számos	 domén‐cserélt	 kiméra	 fehérje	 segítségével,	
melyekben	 a	 dADA2a	 és	 dADA2b	 különböző	 darabjait	 kölcsönösen	 kicseréltem,	 az	
egyes	 régiók	 HAT	 komplex	 specifitásának	 fontosságát	 vizsgáltam.	 A	 kiméra	 ADA2	
fehérjék	in	vivo	funkcióját	a	dADA2a/dADA2b	fehérjék	fenotipikus	menekítésének	és	
hiszton	módosító	képességének	meghatározásával	ada2ad189	és	ada2bd842	null‐mutáns	
háttéren	 teszteltem.	 Megállapítottam,	 hogy	 a	 kiméra	 dADA2	 fehérjék	 Actin‐Gal4	
hajtotta	 túltermelése	 részleges	 fenotípus	 menekítést	 eredményez	 az	 egyik	 vagy	 a	
másik	ada2	mutánsban.	A	Drosophila	politén	kromoszóma	immunfestése	és	western	
Összefoglaló 
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blot	 analízis	 az	 elveszett	 H4K5	 és	 K12	 vagy	 H3K9	 és	 K14	 acetiláció	 visszaállítását	
mutatta	 a	 kiméria	 géneket	 hordozó	 ada2	 mutánsokban.	 Ezen	 túlmenően,	 a	
dADA2b/2a	 kiméra	 transzgének	 expressziójának	hatása	 szintén	 jól	megfigyelhető	 a	
dATAC	 mutánsok	 kromoszóma‐szerkezetének	 megváltozásában.	 Az	 ada2d189	 null	
mutációra	 jellemző	deformálódott	 kromoszóma	 fenotípus	 jelentősen	 javult	 a	 pUAS‐
dAda2bS2a	 vagy	 pUAS‐dAda2bM2a	 kiméra	 transzgént	 kifejező	 mutáns	 állatokban.	
Ezen	megfigyelések	bizonyítják,	hogy	az	ADA2	fehérjék	C‐terminális	doménje	fontos	
szerepet	 játszik	 ezen	 fehérjék	dSAGA	vagy	dATAC	komplexekbe	 való	 beépülésében.	
Továbbá,	a	dADA2	kiméra	fehérjék	használata	menekítésre	és	a	fejlődési	folyamatok	
vizsgálatára	 egy	 kiváló	 stratégiát	 biztosít	 a	 dADA2	 fehérjék	 specifikus	 szerkezeti	
alegységeihez	tartozó	speciális	funkciók	hozzárendeléséhez.	
Biokémiai	 és	 genetikai	 bizonyítékok	 támasztják	 alá,	 hogy	 a	 két	 dADA2b	
izoforma	 különböző	 mennyiségben	 termelődik	 a	 Drosophila	 egyedfejlődése	 alatt	
(Pankotai	et	al.,	2013a).	A	kísérleti	adatok	alapján	megállapítható,	hogy	a	két	dADA2b	
fehérje	 kölcsönhat	 egymással	 és	 ko‐immunoprecipitálható	 dADA3‐mal	 és	 a	 tumor	
szuppresszor	 dp53‐mal	 S2	 sejtekből.	 Ezen	megfigyelések	 alapján	 elmondható,	 hogy	
mindkét	 dADA2b	 fehérje	 működőképes,	 és	 alátámasztja	 a	 lehetőséget,	 hogy	 a	
dADA2bL	 és	 a	 dADA2bS:	 1.	 előfordulhat	 ugyanabban	 a	 HAT	 komplexben;	 2.	
különböző	 SAGA	komplexek	 alegységei.	A	p53‐mal	 történő	kölcsönhatásuk	mindkét	
esetben	az	apoptotikus	útvonalban	betöltött	szerepükre	utal.	
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